Начало >> Статьи >> Литература >> Ведение пациентов с приобретенными пороками сердца

Литература - Ведение пациентов с приобретенными пороками сердца

Оглавление
Ведение пациентов с приобретенными пороками сердца
Обследование пациента с сердечным шумом
Таблица тяжести клапанной патологии
Профилактика эндокардита и ревматической лихорадки
Аортальный стеноз
Показания к замене аортального клапана
Аортальная баллонная вальвотомия, терапия у неоперабельных пациентов
Аортальная регургитация
Сопутствующие заболевания корня аорты, обследование пациентов после замены клапана, пожилые пациенты
Двустворчатый аортальный клапан с расширенной восходящей аортой
Митральный стеноз
Медикаментозная терапия митрального стеноза
Серийные обследования митрального стеноза
Пролапс митрального клапана
Митральная регургитация
Многочисленные болезни клапанов
Патология трикуспидального клапана
Клапанная болезнь сердца из-за препаратов, лучевая болезнь сердца
Обследование и тактика ведения инфекционного эндокардита
Тактика ведения клапанной болезни во время беременности
Тактика ведения врожденной клапанной болезни сердца у подростков и молодых
Хирургические рассмотрения
Обследование во время операции
Обследование во время операции - последующие контрольные визиты
Обследование и лечение болезни коронарных артерий у пациентов с приобретенными пороками
Литература

ЛИТЕРАТУРА
1. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) Circulation 2003; 108:1404-1418.
2. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) J Am Coll Cardiol 2003;42:954-970.
3. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina) J Am Coll Cardiol 2003;41:159-168.
4. Smith Jr SC, Feldman TE, Hirshfeld Jr JW, et al. ACC/AHA/SCAI guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) J Am Coll Cardiol 2006;47:e1-e121.
5. Leatham A. Systolic murmurs Circulation 1958;17:601-611.
6. Braunwald E, Perloff JK. Physical examination of the heart and circulationIn: Zipes DP, Libby P, Bonow RO, Braunwald E, editors. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 7th edition. Philadelphia, PA: Elsevier; 2005. pp. 77.
7. Shaver JA, Salerni R. Auscultation of the heart The Heart. New York, NY: McGraw-Hill; 1994. pp. 253-314.
8. O'Rourke RA, Braunwald E. Physical examination of the cardiovascular system Principles of Internal Medicine. New York, NY: McGraw-Hill; 1998. pp. 1231-1237.
9. Shaver JA. Cardiac auscultation: a cost-effective diagnostic skill Curr Probl Cardiol 1995;20:441-530.
10. Karliner JS, O'Rourke RA, Kearney DJ, Shabetai R. Haemodynamic explanation of why the murmur of mitral regurgitation is independent of cycle length Br Heart J 1973;35:397-401.
11. Lembo NJ, Dell'Italia LJ, Crawford MH, O'Rourke RA. Diagnosis of left-sided regurgitant murmurs by transient arterial occlusion: a new maneuver using blood pressure cuffs Ann Intern Med 1986;105:368-370.
12. Grewe K, Crawford MH, O'Rourke RA. Differentiation of cardiac murmurs by dynamic auscultation Curr Probl Cardiol 1988;13:669-721.
13. Lembo NJ, Dell'Italia LJ, Crawford MH, O'Rourke RA. Bedside diagnosis of systolic murmurs N Engl J Med 1988;318:1572-1578.
14. Marriott HJL. Bedside Cardiac DiagnosisPhiladelphia, PA: Lippincott; 1993. pp. 15721578116, 318.
15. Harvey WP. Cardiac pearls Dis Mon 1994;4041 -13.
16. Yoshida K, Yoshikawa J, Shakudo M, et al. Color Doppler evaluation of valvular regurgitation in normal subjects Circulation 1988;78:840-847.
17. Smythe JF, Teixeira OH, Vlad P, Demers PP, Feldman W. Initial evaluation of heart murmurs: are laboratory tests necessary? Pediatrics 1990;86:497-500.
18. Xu M, McHaffie DJ. Nonspecific systolic murmurs: an audit of the clinical value of echocardiography N Z Med J 1993;106:54-56.
19. Sahn DJ, Maciel BC. Physiological valvular regurgitation: Doppler echocardiography and the potential for iatrogenic heart disease Circulation 1988;78:1075-1077.
20. Choong CY, Abascal VM, Weyman J, et al. Prevalence of valvular regurgitation by Doppler echocardiography in patients with structurally normal hearts by two-dimensional echocardiography Am Heart J 1989;117:636-642.
21. Klein AL, Burstow DJ, Tajik AJ, et al. Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers J Am Soc Echocardiogr 1990;3:54-63.
22. Fink JC, Schmid CH, Selker HP. A decision aid for referring patients with systolic murmurs for echocardiography J Gen Intern Med 1994;9:479-484.
23. Abrams J. Essentials of Cardiac Physical DiagnosisPhiladelphia, PA: Lea & Febiger;
1987.
24. O'Rourke RA. Heart murmur Primary Cardiology. WB Saunders Co; 1998.
25. Northcote RJ, Knight PV, Ballantyne D. Systolic murmurs in pregnancy: value of echocardiographic assessment Clin Cardiol 1985;8:327-328.
26. Mishra M, Chambers JB, Jackson G. Murmurs in pregnancy: an audit of echocardiography BMJ 1992;304:1413-1414.
27. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography J Am Soc Echocardiogr 2003;16:777-802.
28. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association Circulation 1997;96:358-366.
29. Deleted per 2008 Focused Update.
30. Bansal RC. Infective endocarditis Med Clin North Am 1995;79:1205-1240.
3142. Deleted per 2008 Focused Update.
43. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA Lancet 1990;336:1167-1171.
44. Bisno AL. Group A streptococcal infections and acute rheumatic fever N Engl J Med 1991;325:783-793.
45. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals Pediatrics 1995;96:758-764.
46. Selzer A. Changing aspects of the natural history of valvular aortic stenosis N Engl J Med 1987;317:91-98.
47. Dare AJ, Veinot JP, Edwards WD, Tazelaar HD, Schaff HV. New observations on the etiology of aortic valve disease: a surgical pathologic study of 236 cases from 1990 Hum Pathol 1993;24:1330-1338.
48. Stephan PJ, Henry III AC, Hebeler Jr RF, Whiddon L, Roberts WC. Comparison of age, gender, number of aortic valve cusps, concomitant coronary artery bypass grafting, and magnitude of left ventricular-systemic arterial peak systolic gradient in adults having aortic valve replacement for isolated aortic valve stenosis Am J Cardiol 1997;79:166-172.
49. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation Circulation 2005;111:920-925.
50. Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Ryden L, Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves J Am Coll Cardiol 1994;23:1162-1170.
51. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of "degenerative" valvular aortic stenosis: histological and immunohistochemical studies Circulation 1994;90:844-853.
52. O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of "degenerative" valvular aortic stenosis Arterioscler Thromb Vasc Biol 1996;16:523-532.
53. Mohler III ER, Chawla MK, Chang AW, et al. Identification and characterization of calcifying valve cells from human and canine aortic valves J Heart Valve Dis 1999;8:254-260.
54. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low-density lipoprotein in nonrheumatic stenotic aortic valves Arterioscler Thromb Vasc Biol 1999;19:1218-1222.
55. Ghaisas NK, Foley JB, O'Briain DS, Crean P, Kelleher D, Walsh M. Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement J Am Coll Cardiol 2000;36:2257-2262.
56. Mohler III ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves Circulation 2001;103:1522-1528.
57. Rajamannan NM, Sangiorgi G, Springett M, et al. Experimental hypercholesterolemia induces apoptosis in the aortic valve J Heart Valve Dis 2001;10:371-374.
58. O'Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma Circulation 2002;106:2224-2230.
59. Wallby L, Janerot-Sjoberg B, Steffensen T, Broqvist M. T lymphocyte infiltration in nonrheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves Heart 2002;88:348-351.
60. Rajamannan NM, Subramaniam M, Rickard D, et al. Human aortic valve calcification is associated with an osteoblast phenotype Circulation 2003;107:2181-2184.
61. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome Circulation 1997;95:2262-2270.
62. Sasayama S, Ross Jr J, Franklin D, Bloor CM, Bishop S, Dilley RB. Adaptations of the left ventricle to chronic pressure overload Circ Res 1976;38:172-178.
63. Gaasch WH. Left ventricular radius to wall thickness ratio Am J Cardiol 1979;43: 11891194.
64. Spann JF, Bove AA, Natarajan G, Kreulen T. Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis Circulation 1980;62:576-582.
65. Krayenbuehl HP, Hess OM, Ritter M, Monrad ES, Hoppeler H. Left ventricular systolic function in aortic stenosis Eur Heart J 1988;9(Suppl E):19-23.
66. Ross Jr J. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function Prog Cardiovasc Dis 1976;18:255-264.
67. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man Circulation 1979;59:679-688.
68. Huber D, Grimm J, Koch R, Krayenbuehl HP. Determinants of ejection performance in aortic stenosis Circulation 1981;64:126-134.
69. Carabello BA, Green LH, Grossman W, Cohn LH, Koster JK, Collins Jr JJ. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure Circulation 1980;62:42-48.
70. Gaasch WH, Levine HJ, Quinones MA, Alexander JK. Left ventricular compliance: mechanisms and clinical implications Am J Cardiol 1976;38:645-653.
71. Hess OM, Ritter M, Schneider J, Grimm J, Turina M, Krayenbuehl HP. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement Circulation 1984;69:855-865.
72. Murakami T, Hess OM, Gage JE, Grimm J, Krayenbuehl HP. Diastolic filling dynamics in patients with aortic stenosis Circulation 1986;73:1162-1174.
73. Gaasch WH. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction JAMA 1994;271:1276-1280.
74. Stott DK, Marpole DG, Bristow JD, Kloster FE, Griswold HE. The role of left atrial transport in aortic and mitral stenosis Circulation 1970;41:1031-1041.
75. Bache RJ, Vrobel TR, Ring WS, Emery RW, Andersen RW. Regional myocardial blood flow during exercise in dogs with chronic left ventricular hypertrophy Circ Res 1981;48:76-87.
76. Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL. Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries N Engl J Med 1982;307:1362-1366.
77. Carabello BA. Clinical practice: aortic stenosis N Engl J Med 2002;346:677-682.
78. Koyanagi S, Eastham C, Marcus ML. Effects of chronic hypertension and left ventricular hypertrophy on the incidence of sudden cardiac death after coronary artery occlusion in conscious dogs Circulation 1982;65:1192-1197.
79. Koyanagi S, Eastham CL, Harrison DG, Marcus ML. Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy Circ Res 1982;50:55-62.
80. Gaasch WH, Zile MR, Hoshino PK, Weinberg EO, Rhodes DR, Apstein CS. Tolerance of the hypertrophic heart to ischemia: studies in compensated and failing dog hearts with pressure overload hypertrophy Circulation 1990;81:1644-1653.
81. Aurigemma G, Battista S, Orsinelli D, Sweeney A, Pape L, Cuenoud H. Abnormal left ventricular intracavitary flow acceleration in patients undergoing aortic valve replacement for aortic stenosis: a marker for high postoperative morbidity and mortality Circulation 1992;86:926-936.
82. Carroll JD, Carroll EP, Feldman T, et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly Circulation 1992;86:1099-1107.
83. Orsinelli DA, Aurigemma GP, Battista S, Krendel S, Gaasch WH. Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis: a high risk subgroup identified by preoperative relative wall thickness J Am Coll Cardiol 1993;22:1679-1683.
84. Aurigemma GP, Silver KH, McLaughlin M, Mauser J, Gaasch WH. Impact of chamber geometry and gender on left ventricular systolic function in patients >60 years of age with aortic stenosis Am J Cardiol 1994;74:794-798.
85. Faggiano P, Aurigemma GP, Rusconi C, Gaasch WH. Progression of valvular aortic stenosis in adults: literature review and clinical implications Am Heart J 1996;132:408-417.
86. Cheitlin MD, Gertz EW, Brundage BH, Carlson CJ, Quash JA, Bode Jr RS. Rate of progression of severity of valvular aortic stenosis in the adult Am Heart J 1979;98:689-700.
87. Wagner S, Selzer A. Patterns of progression of aortic stenosis: a longitudinal hemodynamic study Circulation 1982;65:709-712.
88. Jonasson R, Jonsson B, Nordlander R, Orinius E, Szamosi A. Rate of progression of severity of valvular aortic stenosis Acta Med Scand 1983;213:51-54.
89. Nestico PF, DePace NL, Kimbiris D, et al. Progression of isolated aortic stenosis: analysis of 29 patients having more than 1 cardiac catheterization Am J Cardiol 1983;52:1054-1058.
90. Otto CM, Pearlman AS, Gardner CL. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography J Am Coll Cardiol 1989;13:545-550.
91. Roger VL, Tajik AJ, Bailey KR, Oh JK, Taylor CL, Seward JB. Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography Am Heart J 1990;119:331 -338.
92. Davies SW, Gershlick AH, Balcon R. Progression of valvar aortic stenosis: a long-term retrospective study Eur Heart J 1991;12:10-14.
93. Faggiano P, Ghizzoni G, Sorgato A, et al. Rate of progression of valvular aortic stenosis in adults Am J Cardiol 1992;70:229-233.
94. Peter M, Hoffmann A, Parker C, Luscher T, Burckhardt D. Progression of aortic stenosis: role of age and concomitant coronary artery disease Chest 1993;103:1715-1719.
95. Brener SJ, Duffy CI, Thomas JD, Stewart WJ. Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction J Am Coll Cardiol 1995;25:305-310.
96. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis N Engl J Med 2000;343:611-617.
97. Vaturi M, Porter A, Adler Y, et al. The natural history of aortic valve disease after mitral valve surgery J Am Coll Cardiol 1999;33:2003-2008.
98. Rosenhek R, Klaar U, Schemper M, et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J 2004;25:199-205.
99. Cosmi JE, Kort S, Tunick PA, et al. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening Arch Intern Med 2002;162:2345-2347.
100. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study J Am Coll Cardiol 1997;29:630-634.
101. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly N Engl J Med 1999;341:142-
147.
102. Olsen MH, Wachtell K, Bella JN, et al. Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy) Am J Cardiol 2005;95:132-136.
103. Taylor Jr HA, Clark BL, Garrison RJ, et al. Relation of aortic valve sclerosis to risk of coronary heart disease in African-Americans Am J Cardiol 2005;95:401-404.
104. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis N Engl J Med 2003;349:343-349. 105. Ross Jr J, Braunwald E. Aortic stenosis Circulation 1968;38:61-67.
106. Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival Circulation 1982;66:1105-1110.
107. Turina J, Hess O, Sepulcri F, Krayenbuehl HP. Spontaneous course of aortic valve disease Eur Heart J 1987;8:471-483.
108. Horstkotte D, Loogen F. The natural history of aortic valve stenosis Eur Heart J 1988;9(Suppl E):57-64.
109. Kelly TA, Rothbart RM, Cooper CM, Kaiser DL, Smucker ML, Gibson RS. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis Am J Cardiol 1988;61:123-130.
110. Sprigings DC, Forfar JC. How should we manage symptomatic aortic stenosis in the patient who is 80 or older? Br Heart J 1995;74:481-484.
111. Iivanainen AM, Lindroos M, Tilvis R, Heikkila J, Kupari M. Natural history of aortic valve stenosis of varying severity in the elderly Am J Cardiol 1996;7897-01.
112. Frank S, Johnson A, Ross Jr J. Natural history of valvular aortic stenosis Br Heart J 1973;35:41-46.
113. Chizner MA, Pearle DL, deLeon Jr AC. The natural history of aortic stenosis in adults Am Heart J 1980;99:419-424.
114. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis J Am Coll Cardiol 1990;15:1012-1017.
115. Kennedy KD, Nishimura RA, Holmes Jr DR, Bailey KR. Natural history of moderate aortic stenosis J Am Coll Cardiol 1991;17:313-319.
116. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up Circulation 2005;111:3290-3295.
117. Amato MC, Moffa PJ, Werner KE, Ramires JA. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing Heart 2001;86:381-386.
118. Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis Eur Heart J 2005;26:1309-1313.
119. Munt B, Legget ME, Kraft CD, Miyake-Hull CY, Fujioka M, Otto CM. Physical examination in valvular aortic stenosis: correlation with stenosis severity and prediction of clinical outcome Am Heart J 1999;137:298-306.
120. Nylander E, Ekman I, Marklund T, Sinnerstad B, Karlsson E, Wranne B. Severe aortic stenosis in elderly patients Br Heart J 1986;55:480-487.
121. Atwood JE, Kawanishi S, Myers J, Froelicher VF. Exercise testing in patients with aortic stenosis Chest 1988;93:1083-1087.
122. Clyne CA, Arrighi JA, Maron BJ, Dilsizian V, Bonow RO, Cannon III RO. Systemic and left ventricular responses to exercise stress in asymptomatic patients with valvular aortic stenosis Am J Cardiol 1991;68:1469-1476.
123. Otto CM, Pearlman AS, Kraft CD, Miyake-Hull CY, Burwash IG, Gardner CJ. Physiologic changes with maximal exercise in asymptomatic valvular aortic stenosis assessed by Doppler echocardiography J Am Coll Cardiol 1992;20:1160-1167.
124. Alborino D, Hoffmann JL, Fournet PC, Bloch A. Value of exercise testing to evaluate the indication for surgery in asymptomatic patients with valvular aortic stenosis J Heart Valve Dis 2002;11:204-209.
125. Takeda S, Rimington H, Chambers J. Prediction of symptom-onset in aortic stenosis: a comparison of pressure drop/flow slope and haemodynamic measures at rest Int J Cardiol 2001;81:131-137.
126. Wilmshurst PT, Stevenson RN, Griffiths H, Lord JR. A case-control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis Heart 1997;78:475-479.
127. Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis: implications for secondary prevention Circulation 2000;101:2497-2502.
128. Ngo MV, Gottdiener JS, Fletcher RD, Fernicola DJ, Gersh BJ. Smoking and obesity are associated with the progression of aortic stenosis Am J Geriatr Cardiol 2001;10:86-90.
129. Chandra HR, Goldstein JA, Choudhary N, et al. Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation J Am Coll Cardiol 2004;43:169-175.
130. Rajamannan NM, Otto CM. Targeted therapy to prevent progression of calcific aortic stenosis Circulation 2004;110:1180-1182.
131. Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons Am J Cardiol 2001;88:693-695.
132. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis Circulation 2001;104:2205-2209.
133. Shavelle DM, Takasu J, Budoff MJ, Mao S, Zhao XQ, O'Brien KD. HMG CoA reductase inhibitor (statin) and aortic valve calcium Lancet 2002;359:1125-1126.
134. Pohle K, Maffert R, Ropers D, et al. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors Circulation 2001;104:1927-1932.
135. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community J Am Coll Cardiol 2002;40:1723-1730. 136. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis Circulation 2004;110:1291-1295.
137. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis N Engl J Med 2005;352:2389-2397.
138. Bonow RO, Cheitlin M, Crawford M, Douglas PS. 36th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalties. Task Force 3: Valvular Heart Disease. J Am Coll Cardiol 2005;14:1334-1340.
139. Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts Am Heart J 1951;41:1-29.
140. Burwash IG, Hay KM, Chan KL. Hemodynamic stability of valve area, valve resistance, and stroke work loss in aortic stenosis: a comparative analysis J Am Soc Echocardiogr 2002;15:814-822.
141. Bache RJ, Wang Y, Jorgensen CR. Hemodynamic effects of exercise in isolated valvular aortic stenosis Circulation 1971;44:1003-1013.
142. deFilippi CR, Willett DL, Brickner ME, et al. Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients Am J Cardiol 1995;75:191-194.
143. Bermejo J, Garcia-Fernandez MA, Torrecilla EG, et al. Effects of dobutamine on Doppler echocardiographic indexes of aortic stenosis J Am Coll Cardiol 1996;28:1206-1213.
144. Lin SS, Roger VL, Pascoe R, Seward JB, Pellikka PA. Dobutamine stress Doppler hemodynamics in patients with aortic stenosis: feasibility, safety, and surgical correlations Am Heart J 1998;136:1010-1016.
145. Monin JL, Monchi M, Gest V, Duval-Moulin AM, Dubois-Rande JL, Gueret P. Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography J Am Coll Cardiol 2001;37:2101-2107.
146. Schwammenthal E, Vered Z, Moshkowitz Y, et al. Dobutamine echocardiography in patients with aortic stenosis and left ventricular dysfunction: predicting outcome as a function of management strategy Chest 2001;119:1766-1777.
147. Nishimura RA, Grantham JA, Connolly HM, Schaff HV, Higano ST, Holmes Jr DR. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory Circulation 2002;106:809 813.
148. Monin JL, Quere JP, Monchi M, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics Circulation 2003;108:319-324.
149. Otto CM. Valvular aortic stenosis: disease severity and timing of intervention J Am Coll Cardiol 2006;47:2141-2151.
150. Smith N, McAnulty JH, Rahimtoola SH. Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement Circulation 1978;58:255-264.
151. Murphy ES, Lawson RM, Starr A, Rahimtoola SH. Severe aortic stenosis in patients 60 years of age or older: left ventricular function and 10-year survival after valve replacement Circulation 1981;64:II184-II188.
152. Lund O. Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis: reasons for earlier operative intervention Circulation 1990;82:124-
139.
153. Kouchoukos NT, Davila-Roman VG, Spray TL, Murphy SF, Perrillo JB. Replacement of the aortic root with a pulmonary autograft in children and young adults with aortic-valve disease N Engl J Med 1994;330:1-6.
154. Connolly HM, Oh JK, Orszulak TA, et al. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction: prognostic indicators Circulation 1997;95:2395-2400.
155. Kvidal P, Bergstrom R, Horte LG, Stahle E. Observed and relative survival after aortic valve replacement J Am Coll Cardiol 2000;35:747-756.
156. Brogan III WC, Grayburn PA, Lange RA, Hillis LD. Prognosis after valve replacement in patients with severe aortic stenosis and a low transvalvular pressure gradient J Am Coll Cardiol 1993;21:1657-1660.
157. Connolly HM, Oh JK, Schaff HV, et al. Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction: result of aortic valve replacement in 52 patients Circulation 2000;101:1940-1946.
158. Pereira JJ, Lauer MS, Bashir M, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction J Am Coll Cardiol 2002;39:1356-1363.
159. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE) Eur J Cardiothorac Surg 1999;16:9-13.
160. Nashef SA, Roques F, Hammill BG, et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery Eur J Cardiothorac Surg 2002;22:101-105.
161. Shroyer AL, Coombs LP, Peterson ED, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models Ann Thorac Surg 2003;75:1856-1864.
162. Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, Taylor KM. Generic, simple risk stratification model for heart valve surgery Circulation 2005;112:224-231.
163. Carabello BA. Timing of valve replacement in aortic stenosis: moving closer to perfection Circulation 1997;95:2241-2243.
164. Edwards FH, Peterson ED, Coombs LP, et al. Prediction of operative mortality after valve replacement surgery J Am Coll Cardiol 2001;37:885-892.
165. Society of Thoracic Surgeons National Cardiac Surgery Database http://www.sts.ors/documents/pdf/STS-ExecutiveSummaryFall2005.pdf 2001Acessed November 2005.
166. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States N Engl J Med 2002;346:1128-1137.
167. Goodney PP, O'Connor GT, Wennberg DE, Birkmeyer JD. Do hospitals with low mortality rates in coronary artery bypass also perform well in valve replacement? Ann Thorac Surg 2003;76:1131-1136.
168. Banbury MK, Cosgrove III DM, White JA, Blackstone EH, Frater RW, Okies JE. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis Ann Thorac Surg 2001;72:753-757.
169. Byrne JG, Karavas AN, Mihaljevic T, Rawn JD, Aranki SF, Cohn LH. Role of the cryopreserved homograft in isolated elective aortic valve replacement Am J Cardiol 2003;91:616-
619.
170. Yacoub M, Rasmi NR, Sundt TM, et al. Fourteen-year experience with homovital homografts for aortic valve replacement J Thorac Cardiovasc Surg 1995;110:186-193.
171. O'Brien MF, Stafford EG, Gardner MA, et al. Allograft aortic valve replacement: longterm follow-up Ann Thorac Surg 1995;60:S65-S70.
172. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves N Engl J Med 1996;335:407-416.
173. Banbury MK, Cosgrove III DM, Lytle BW, Smedira NG, Sabik JF, Saunders CR. Longterm results of the Carpentier-Edwards pericardial aortic valve: a 12-year follow-up Ann Thorac Surg 1998;66:S73-S76.
174. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial J Am Coll Cardiol 2000;36:1152-1158.
175. Akins CW. Mechanical cardiac valvular prostheses Ann Thorac Surg 1991;52:161-172.
176. Kvidal P, Bergstrom R, Malm T, Stahle E. Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis Eur Heart J 2000;21:1099-1111.
177. Emery RW, Erickson CA, Arom KV, et al. Replacement of the aortic valve in patients under 50 years of age: long-term follow-up of the St. Jude Medical prosthesis Ann Thorac Surg 2003;75:1815-1819.
178. Murday AJ, Hochstitzky A, Mansfield J, et al. A prospective controlled trial of St. Jude versus Starr Edwards aortic and mitral valve prostheses Ann Thorac Surg 2003;76:66-73.
179. Lund O, Larsen KE. Cardiac pathology after isolated valve replacement for aortic stenosis in relation to preoperative patient status: early and late autopsy findings Scand J Thorac Cardiovasc Surg 1989;23:263-270.
180. Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis Circulation 2004;109:2302-2308.
181. Moreira FC, Manfroi WC, Werutsky G, Bittencourt JA. Management of mild aortic stenosis in patients undergoing coronary bypass surgery Arq Bras Cardiol 2001;77:494-499.
182. Filsoufi F, Aklog L, Adams DH, Byrne JG. Management of mild to moderate aortic stenosis at the time of coronary artery bypass grafting J Heart Valve Dis 2002;11(Suppl 1):S45-S49.
183. Smith WT, Ferguson Jr TB, Ryan T, Landolfo CK, Peterson ED. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic
valve replacement?. A decision analysis approach to the surgical dilemma. J Am Coll Cardiol 2004;44:1241-1247.
184. Pereira JJ, Balaban K, Lauer MS, Lytle B, Thomas JD, Garcia MJ. Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery Am J Med 2005;118:735-742.
185. Gillinov AM, Garcia MJ. When is concomitant aortic valve replacement indicated in patients with mild to moderate stenosis undergoing coronary revascularization? Curr Cardiol Rep 2005;7:101-104.
186. Eslami M, Rahimtoola SH. Prophylactic aortic valve replacement in older patients for mild aortic stenosis during coronary bypass surgery Am J Geriatr Cardiol 2003;12:197-200.
187. Karagounis A, Valencia O, Chandrasekaran V, Smith J, Brecker S, Jahangiri M. Management of patients undergoing coronary artery bypass graft surgery with mild to moderate aortic stenosis J Heart Valve Dis 2004;13:369-373.
188. Lababidi Z, Wu JR, Walls JT. Percutaneous balloon aortic valvuloplasty: results in 23 patients Am J Cardiol 1984;53:194-197.
189. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1986;1:63-67.
190. Safian RD, Berman AD, Diver DJ, et al. Balloon aortic valvuloplasty in 170 consecutive patients N Engl J Med 1988;319:125-130.
191. McKay RG, Safian RD, Lock JE, et al. Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative, and percutaneous valvuloplasty studies Circulation 1986;74:119-125.
192. Safian RD, Mandell VS, Thurer RE, et al. Postmortem and intraoperative balloon valvuloplasty of calcific aortic stenosis in elderly patients: mechanisms of successful dilation J Am Coll Cardiol 1987;9:655-660.
193. Isner JM, Samuels DA, Slovenkai GA, et al. Mechanism of aortic balloon valvuloplasty: fracture of valvular calcific deposits Ann Intern Med 1988;108:377-380.
194. Letac B, Cribier A, Koning R, Bellefleur JP. Results of percutaneous transluminal valvuloplasty in 218 adults with valvular aortic stenosis Am J Cardiol 1988;62:598-605.
195. Block PC, Palacios IF. Clinical and hemodynamic follow-up after percutaneous aortic valvuloplasty in the elderly Am J Cardiol 1988;62:760-763.
196. Sherman W, Hershman R, Lazzam C, Cohen M, Ambrose J, Gorlin R. Balloon valvuloplasty in adult aortic stenosis: determinants of clinical outcome Ann Intern Med 1989;110:421-425.
197. Brady ST, Davis CA, Kussmaul WG, Laskey WK, Hirshfeld Jr JW, Herrmann HC. Percutaneous aortic balloon valvuloplasty in octogenarians: morbidity and mortality Ann Intern Med 1989;110:761-766.
198. Hayes SN, Holmes Jr DR, Nishimura RA, Reeder GS. Palliative percutaneous aortic balloon valvuloplasty before noncardiac operations and invasive diagnostic procedures Mayo Clin Proc 1989;64:753-757.
199. Fields CD, Rosenfield K, Lasordo DW, Isner JM. Percutaneous balloon valvuloplasty: current status Curr Opinion Cardiol 1989;4:229-242.
200. Ferguson III JJ, Riuli EP, Massumi A, et al. Balloon aortic valvuloplasty: the Texas Heart Institute experience Tex Heart Inst J 1990;17:23 -30.
201. Berland J, Cribier A, Savin T, Lefebvre E, Koning R, Letac B. Percutaneous balloon valvuloplasty in patients with severe aortic stenosis and low ejection fraction: immediate results and 1-year follow-up Circulation 1989;79:1189-1196.
202. Davidson CJ, Harrison JK, Leithe ME, Kisslo KB, Bashore TM. Failure of balloon aortic valvuloplasty to result in sustained clinical improvement in patients with depressed left ventricular function Am J Cardiol 1990;65:72-77.
203. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty: insights into prognosis of valvular aortic stenosis Circulation 1994;89:642-650.
204. Lieberman EB, Bashore TM, Hermiller JB, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival J Am Coll Cardiol 1995;26:1522-1528.
205. Block PC. Aortic valvuloplasty—a valid alternative? N Engl J Med 1988;319:169-171.
206. Nishimura RA, Holmes Jr DR, Reeder GS. Percutaneous balloon valvuloplasty Mayo Clin Proc 1990;65:198-220.
207. Rahimtoola SH. Catheter balloon valvuloplasty for severe calcific aortic stenosis: a limited role J Am Coll Cardiol 1994;23:1076-1078.
208. O'Keefe Jr JH, Shub C, Rettke SR. Risk of noncardiac surgical procedures in patients with aortic stenosis Mayo Clin Proc 1989;64:400-405.
209. Torsher LC, Shub C, Rettke SR, Brown DL. Risk of patients with severe aortic stenosis undergoing noncardiac surgery Am J Cardiol 1998;81:448-452.
210. Raymer K, Yang H. Patients with aortic stenosis: cardiac complications in non-cardiac surgery Can J Anaesth 1998;45:855-859.
211. Brighouse D. Anaesthesia for caesarean section in patients with aortic stenosis: the case for regional anaesthesia Anaesthesia 1998;53:107-109.
212. Christ M, Sharkova Y, Geldner G, Maisch B. Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery Chest 2005;128:2944-2953.
213. Khot UN, Novaro GM, Popovic ZB, et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis N Engl J Med 2003;348:1756-1763.
214. Bloomfield P, Wheatley DJ, Prescott RJ, Miller HC. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses N Engl J Med 1991;324:573 -579.
215. Tsai TP, Denton TA, Chaux A, et al. Results of coronary artery bypass grafting and/or aortic or mitral valve operation in patients > or = 90 years of age Am J Cardiol 1994;74:960-962.
216. Logeais Y, Langanay T, Roussin R, et al. Surgery for aortic stenosis in elderly patients: a study of surgical risk and predictive factors Circulation 1994;90:2891-2898.
217. Bouma BJ, van den Brink RB, van der Meulen JH, et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences Heart 1999;82:143 -148.
218. Abdul-Hamid AR, Mulley GP. Why do so few older people with aortic stenosis have valve replacement surgery? Age Ageing 1999;28:261-264.
219. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714-2720.
220. Cigarroa JE, Isselbacher EM, DeSanctis RW, Eagle KA. Diagnostic imaging in the evaluation of suspected aortic dissection: old standards and new directions N Engl J Med 1993;328:35-43.
221. Nienaber CA, von Kodolitsch Y, Nicolas V, et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures N Engl J Med 1993;328:1-9.
222. Smith MD, Cassidy JM, Souther S, et al. Transesophageal echocardiography in the diagnosis of traumatic rupture of the aorta N Engl J Med 1995;332:356-362.
223. Rahimtoola SH. Recognition and management of acute aortic regurgitation Heart Dis Stroke 1993;2:217-221.
224. Kern MJ, Serota H, Callicoat P, et al. Use of coronary arteriography in the preoperative management of patients undergoing urgent repair of the thoracic aorta Am Heart J 1990; 119:143 -
148.
225. Israel DH, Sharma SK, Ambrose JA, Ergin MA, Griepp RR. Cardiac catheterization and selective coronary angiography in ascending aortic aneurysm or dissection Cathet Cardiovasc Diagn 1994;32:232-237.
226. Rizzo RJ, Aranki SF, Aklog L, et al. Rapid noninvasive diagnosis and surgical repair of acute ascending aortic dissection: improved survival with less angiography J Thorac Cardiovasc Surg 1994;108:567-574.
227. Penn MS, Smedira N, Lytle B, Brener SJ. Does coronary angiography before emergency aortic surgery affect in-hospital mortality? J Am Coll Cardiol 2000;35:889-894.
228. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle J Clin Invest 1975;56:56-64.
229. Ross Jr J, McCullagh WH. Nature of enhanced performance of the dilated left ventricle in the dog during chronic volume overloading Circ Res 1972;30549-6.
230. Wisenbaugh T, Spann JF, Carabello BA. Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation J Am Coll Cardiol 1984;3:916-923.
231. Carabello BA. Aortic regurgitation: a lesion with similarities to both aortic stenosis and mitral regurgitation Circulation 1990;82:1051-1053.
232. Ricci DR. Afterload mismatch and preload reserve in chronic aortic regurgitation Circulation 1982;66:826-834.
233. Ross Jr J. Afterload mismatch in aortic and mitral valve disease: implications for surgical therapy J Am Coll Cardiol 1985;5:811-826.
234. Nitenberg A, Foult JM, Antony I, Blanchet F, Rahali M. Coronary flow and resistance reserve in patients with chronic aortic regurgitation, angina pectoris and normal coronary arteries J Am Coll Cardiol 1988;11:478-486.
235. Gaasch WH, Andrias CW, Levine HJ. Chronic aortic regurgitation: the effect of aortic valve replacement on left ventricular volume, mass and function Circulation 1978;58:825-836.
236. Schwarz F, Flameng W, Langebartels F, Sesto M, Walter P, Schlepper M. Impaired left ventricular function in chronic aortic valve disease: survival and function after replacement by Bjork-Shiley prosthesis Circulation 1979;60:48-58.
237. Borer JS, Rosing DR, Kent KM, et al. Left ventricular function at rest and during exercise after aortic valve replacement in patients with aortic regurgitation Am J Cardiol 1979;44:1297-1305.
238. Clark DG, McAnulty JH, Rahimtoola SH. Valve replacement in aortic insufficiency with left ventricular dysfunction Circulation 1980;61:411-421.
239. Toussaint C, Cribier A, Cazor JL, Soyer R, Letac B. Hemodynamic and angiographic evaluation of aortic regurgitation 8 and 27 months after aortic valve replacement Circulation 1981;64:456-463.
240. Carroll JD, Gaasch WH, Zile MR, Levine HJ. Serial changes in left ventricular function after correction of chronic aortic regurgitation: dependence on early changes in preload and subsequent regression of hypertrophy Am J Cardiol 1983;51:476-482.
241. Bonow RO, Rosing DR, Maron BJ, et al. Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction Circulation 1984;70:570-579.
242. Fioretti P, Roelandt J, Sclavo M, et al. Postoperative regression of left ventricular dimensions in aortic insufficiency: a long-term echocardiographic study J Am Coll Cardiol 1985;5:856-861.
243. Carabello BA, Usher BW, Hendrix GH, Assey ME, Crawford FA, Leman RB. Predictors of outcome for aortic valve replacement in patients with aortic regurgitation and left ventricular dysfunction: a change in the measuring stick J Am Coll Cardiol 1987;10:991-997.
244. Taniguchi K, Nakano S, Hirose H, et al. Preoperative left ventricular function: minimal requirement for successful late results of valve replacement for aortic regurgitation J Am Coll Cardiol 1987;10:510-518.
245. Bonow RO, Dodd JT, Maron BJ, et al. Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation Circulation 1988;78:1108-1120.
246. Borer JS, Herrold EM, Hochreiter C, et al. Natural history of left ventricular performance at rest and during exercise after aortic valve replacement for aortic regurgitation Circulation 1991; 84: III133 -III139.
247. Cohn PF, Gorlin R, Cohn LH, Collins Jr JJ. Left ventricular ejection fraction as a prognostic guide in surgical treatment of coronary and valvular heart disease Am J Cardiol 1974;34136-1.
248. Copeland JG, Griepp RB, Stinson EB, Shumway NE. Long-term follow-up after isolated aortic valve replacement J Thorac Cardiovasc Surg 1977;74:875-889.
249. Herreman F, Ameur A, de Vernejoul F, et al. Pre- and postoperative hemodynamic and cineangiocardiographic assessment of left ventricular function in patients with aortic regurgitation Am Heart J 1979;98:63-72.
250. Cunha CL, Giuliani ER, Fuster V, Seward JB, Brandenburg RO, McGoon DC. Preoperative M-mode echocardiography as a predictor of surgical results in chronic aortic insufficiency J Thorac Cardiovasc Surg 1980;79256-5.
251. Forman R, Firth BG, Barnard MS. Prognostic significance of preoperative left ventricular ejection fraction and valve lesion in patients with aortic valve replacement Am J Cardiol 1980;45:1120-1125.
252. Greves J, Rahimtoola SH, McAnulty JH, et al. Preoperative criteria predictive of late survival following valve replacement for severe aortic regurgitation Am Heart J 1981;101:300-308.
253. Gaasch WH, Carroll JD, Levine HJ, Criscitiello MG. Chronic aortic regurgitation: prognostic value of left ventricular end-systolic dimension and end-diastolic radius/thickness ratio J Am Coll Cardiol 1983;1:775-782.
254. Bonow RO, Picone AL, McIntosh CL, et al. Survival and functional results after valve replacement for aortic regurgitation from 1976 to 1983: impact of preoperative left ventricular function Circulation 1985;72:1244-1256.
255. Carabello BA, Williams H, Gash AK, et al. Hemodynamic predictors of outcome in patients undergoing valve replacement Circulation 1986;74:1309-1316.
256. Michel PL, Iung B, Abou JS, et al. The effect of left ventricular systolic function on long term survival in mitral and aortic regurgitation J Heart Valve Dis 1995;4(Suppl 2):S160-S168.
257. Henry WL, Bonow RO, Borer JS, et al. Observations on the optimum time for operative intervention for aortic regurgitation, I: evaluation of the results of aortic valve replacement in symptomatic patients Circulation 1980;61:471-483.
258. Kumpuris AG, Quinones MA, Waggoner AD, Kanon DJ, Nelson JG, Miller RR. Importance of preoperative hypertrophy, wall stress and end-systolic dimension as echocardiographic predictors of normalization of left ventricular dilatation after valve replacement in chronic aortic insufficiency Am J Cardiol 1982;49:1091-1100.
259. Fioretti P, Roelandt J, Bos RJ, et al. Echocardiography in chronic aortic insufficiency: is valve replacement too late when left ventricular end-systolic dimension reaches 55 mm? Circulation 1983;67:216-221.
260. Stone PH, Clark RD, Goldschlager N, Selzer A, Cohn K. Determinants of prognosis of patients with aortic regurgitation who undergo aortic valve replacement J Am Coll Cardiol 1984;3:1118-1126.
261. Daniel WG, Hood Jr WP, Siart A, et al. Chronic aortic regurgitation: reassessment of the prognostic value of preoperative left ventricular end-systolic dimension and fractional shortening Circulation 1985;71:669-680.
262. Cormier B, Vahanian A, Luxereau P, Kassab R, Acar J. Should asymptomatic or mildly symptomatic aortic regurgitation be operated on? Z Kardiol 1986;75(Suppl 2): 141 -145.
263. Sheiban I, Trevi GP, Casarotto D, et al. Aortic valve replacement in patients with aortic incompetence: preoperative parameters influencing long-term results Z Kardiol 1986;75(Suppl 2):146-154.
264. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Aortic regurgitation complicated by extreme left ventricular dilation: long-term outcome after surgical correction J Am Coll Cardiol 1996;27:670-677.
265. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms J Am Coll Cardiol 1997;30:746-752.
266. Turina J, Milincic J, Seifert B, Turina M. Valve replacement in chronic aortic regurgitation: true predictors of survival after extended follow-up Circulation 1998;98:II100-II106.
267. Tornos P, Sambola A, Permanyer-Miralda G, Evangelista A, Gomez Z, Soler-Soler J. Long-term outcome of surgically treated aortic regurgitation: influence of guideline adherence toward early surgery J Am Coll Cardiol 2006;47:1012-1017.
268. Bonow RO, Rosing DR, McIntosh CL, et al. The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function Circulation 1983;68:509-517.
269. Scognamiglio R, Fasoli G, Dalla VS. Progression of myocardial dysfunction in asymptomatic patients with severe aortic insufficiency Clin Cardiol 1986;9:151-156.
270. Siemienczuk D, Greenberg B, Morris C, et al. Chronic aortic insufficiency: factors associated with progression to aortic valve replacement Ann Intern Med 1989;110:587-592.
271. Bonow RO, Lakatos E, Maron BJ, Epstein SE. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function Circulation 1991;84:1625-1635.
272. Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla VS. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function N Engl J Med 1994;331:689-694.
273. Tornos MP, Olona M, Permanyer-Miralda G, et al. Clinical outcome of severe asymptomatic chronic aortic regurgitation: a long-term prospective follow-up study Am Heart J 1995;130:333-339.
274. Ishii K, Hirota Y, Suwa M, Kita Y, Onaka H, Kawamura K. Natural history and left ventricular response in chronic aortic regurgitation Am J Cardiol 1996;78:357-361.
275. Borer JS, Hochreiter C, Herrold EM, et al. Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance Circulation 1998;97:525-534.
276. Tarasoutchi F, Grinberg M, Spina GS, et al. Ten-year clinical laboratory follow-up after application of a symptom-based therapeutic strategy to patients with severe chronic aortic regurgitation of predominant rheumatic etiology J Am Coll Cardiol 2003;41:1316-1324.
277. Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler-Soler J. Long-term vasodilator therapy in patients with severe aortic regurgitation N Engl J Med 2005;353:1342-1349.
278. Greenberg B, Massie B, Bristow JD, et al. Long-term vasodilator therapy of chronic aortic insufficiency: a randomized double-blinded, placebo-controlled clinical trial Circulation 1988;78:92-103.
279. Shen WF, Roubin GS, Choong CY, et al. Evaluation of relationship between myocardial contractile state and left ventricular function in patients with aortic regurgitation Circulation 1985;71:31-38.
280. Kawanishi DT, McKay CR, Chandraratna PA, et al. Cardiovascular response to dynamic exercise in patients with chronic symptomatic mild-to-moderate and severe aortic regurgitation Circulation 1986;73:62-72.
281. Henry WL, Bonow RO, Rosing DR, Epstein SE. Observations on the optimum time for operative intervention for aortic regurgitation, II: serial echocardiographic evaluation of asymptomatic patients Circulation 1980;61:484-492.
282. McDonald IG, Jelinek VM. Serial M-mode echocardiography in severe chronic aortic regurgitation Circulation 1980;62:1291-1296.
283. Bonow RO. Radionuclide angiography in the management of asymptomatic aortic regurgitation Circulation 1991;84:I296-I302.
284. Hegglin R, Scheu H, Rothlin M. Aortic insufficiency Circulation 1968;38:77-92.
285. Spagnuolo M, Kloth H, Taranta A, Doyle E, Pasternack B. Natural history of rheumatic aortic regurgitation: criteria predictive of death, congestive heart failure, and angina in young patients Circulation 1971;44:368-380.
286. Rapaport E. Natural history of aortic and mitral valve disease Am J Cardiol 1975;35:221-227.
287. Aronow WS, Ahn C, Kronzon I, Nanna M. Prognosis of patients with heart failure and unoperated severe aortic valvular regurgitation and relation to ejection fraction Am J Cardiol 1994;74:286-288.
288. Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice: a long-term follow-up study Circulation 1999;99:1851-1857.
289. Parker E, Craige E, Hood Jr WP. The Austin Flint murmur and the a wave of the apexcardiogram in aortic regurgitation Circulation 1971;43:349-359.
290. Fortuin NJ, Craige E. On the mechanism of the Austin Flint murmur Circulation 1972;45558-0.
291. Harvey WP, Corrado MA, Perloff JK. "Right-sided" murmurs of aortic insufficiency (diastolic murmurs better heard to the right of the sternum rather than to the left) Am J Med Sci 1963;245:533-543.
292. Teague SM, Heinsimer JA, Anderson JL, et al. Quantification of aortic regurgitation utilizing continuous wave Doppler ultrasound J Am Coll Cardiol 1986;8:592-599.
293. Labovitz AJ, Ferrara RP, Kern MJ, Bryg RJ, Mrosek DG, Williams GA. Quantitative evaluation of aortic insufficiency by continuous wave Doppler echocardiography J Am Coll Cardiol 1986;8:1341-1347.
294. Xie GY, Berk MR, Smith, MD, DeMaria AN. A simplified method for determining regurgitant fraction by Doppler echocardiography in patients with aortic regurgitation J Am Coll Cardiol 1994;24:1041-1045.
295. Borer JS, Bacharach SL, Green MV, et al. Exercise-induced left ventricular dysfunction in symptomatic and asymptomatic patients with aortic regurgitation: assessment with radionuclide cineangiography Am J Cardiol 1978;42:351-357.
296. Lewis SM, Riba AL, Berger HJ, et al. Radionuclide angiographic exercise left ventricular performance in chronic aortic regurgitation: relationship to resting echographic ventricular dimensions and systolic wall stress index Am Heart J 1982;103:498-504.
297. Huxley RL, Gaffney FA, Corbett JR, et al. Early detection of left ventricular dysfunction in chronic aortic regurgitation as assessed by contrast angiography, echocardiography, and rest and exercise scintigraphy Am J Cardiol 1983;51:1542-1550.
298. Iskandrian AS, Hakki AH, Manno B, Amenta A, Kane SA. Left ventricular function in chronic aortic regurgitation J Am Coll Cardiol 1983;1:1374-1380.
299. Gerson MC, Engel PJ, Mantil JC, Bucher PD, Hertzberg VS, Adolph RJ. Effects of dynamic and isometric exercise on the radionuclide-determined regurgitant fraction in aortic insufficiency J Am Coll Cardiol 1984;3:98-106.
300. Goldman ME, Packer M, Horowitz SF, et al. Relation between exercise-induced changes in ejection fraction and systolic loading conditions at rest in aortic regurgitation J Am Coll Cardiol 1984;3:924-929.
301. Greenberg B, Massie B, Thomas D, et al. Association between the exercise ejection fraction response and systolic wall stress in patients with chronic aortic insufficiency Circulation 1985;71:458-465.
302. Massie BM, Kramer BL, Loge D, et al. Ejection fraction response to supine exercise in asymptomatic aortic regurgitation: relation to simultaneous hemodynamic measurements J Am Coll Cardiol 1985;5:847-855.
303. Wilson RA, Greenberg BH, Massie BM, et al. Left ventricular response to submaximal and maximal exercise in asymptomatic aortic regurgitation Am J Cardiol 1988;62:606-610.
304. Bolen JL, Alderman EL. Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation Circulation 1976;53:879-883.
305. Miller RR, Vismara LA, DeMaria AN, Salel AF, Mason DT. Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume Am J Cardiol 1976;38:564-567.
306. Greenberg BH, DeMots H, Murphy E, Rahimtoola S. Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency Circulation 1980;62:49-55.
307. Greenberg BH, DeMots H, Murphy E, Rahimtoola SH. Mechanism for improved cardiac performance with arteriolar dilators in aortic insufficiency Circulation 1981;63:263-268.
308. Fioretti P, Benussi B, Scardi S, Klugmann S, Brower RW, Camerini F. Afterload reduction with nifedipine in aortic insufficiency Am J Cardiol 1982;49:1728-1732.
309. Shen WF, Roubin GS, Hirasawa K, et al. Noninvasive assessment of acute effects of nifedipine on rest and exercise hemodynamics and cardiac function in patients with aortic regurgitation J Am Coll Cardiol 1984;4:902-907.
310. Scognamiglio R, Fasoli G, Visintin L, Dalla-Volta S. Effects of unloading and positive inotropic interventions on left ventricular function in asymptomatic patients with chronic severe aortic insufficiency Clin Cardiol 1987;10:804-810.
311. Rothlisberger C, Sareli P, Wisenbaugh T. Comparison of single-dose nifedipine and captopril for chronic severe aortic regurgitation Am J Cardiol 1993;72:799-804.
312. Levine HJ, Gaasch WH. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves J Am Coll Cardiol 1996;28:1083-1091.
313. Sondergaard L, Aldershvile J, Hildebrandt P, Kelbaek H, Stahlberg F, Thomsen C. Vasodilatation with felodipine in chronic asymptomatic aortic regurgitation Am Heart J 2000;139:667-674.
314. Scognamiglio R, Fasoli G, Ponchia A, Dalla-Volta S. Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation J Am Coll Cardiol 1990;16:424-429.
315. Wisenbaugh T, Sinovich V, Dullabh A, Sareli P. Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation J Heart Valve Dis 1994;3:197-204.
316. Lin M, Chiang HT, Lin SL, et al. Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy J Am Coll Cardiol 1994;24:1046-1053.
317. Schon HR, Dorn R, Barthel P, Schomig A. Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation J Heart Valve Dis 1994;3:500-509.
318. Keller AM, Peshock RM, Malloy CR, et al. In vivo measurement of myocardial mass using nuclear magnetic resonance imaging J Am Coll Cardiol 1986;8:113-117.
319. Van Rossum AC, Visser FC, Sprenger M, Van Eenige MJ, Valk J, Roos JP. Evaluation of magnetic resonance imaging for determination of left ventricular ejection fraction and comparison with angiography Am J Cardiol 1988;62:628-633.
320. Buser PT, Auffermann W, Holt WW, et al. Noninvasive evaluation of global left ventricular function with use of cine nuclear magnetic resonance J Am Coll Cardiol 1989;13:1294-1300.
321. Cranney GB, Lotan CS, Dean L, Baxley W, Bouchard A, Pohost GM. Left ventricular volume measurement using cardiac axis nuclear magnetic resonance imaging: validation by calibrated ventricular angiography Circulation 1990;82:154-163.
322. Benjelloun H, Cranney GB, Kirk KA, Blackwell GG, Lotan CS, Pohost GM. Interstudy reproducibility of biplane cine nuclear magnetic resonance measurements of left ventricular function Am J Cardiol 1991;67:1413-1420.
323. Sechtem U, Pflugfelder PW, Cassidy MM, et al. Mitral or aortic regurgitation: quantification of regurgitant volumes with cine MR imaging Radiology 1988;167:425-430.
324. Dulce MC, Mostbeck GH, O'Sullivan M, Cheitlin M, Caputo GR, Higgins CB. Severity of aortic regurgitation: interstudy reproducibility of measurements with velocity-encoded cine MR imaging Radiology 1992;185:235-240.
325. Fujita N, Chazouilleres AF, Hartiala JJ, et al. Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging J Am Coll Cardiol 1994;23:951-958.
326. Walker PG, Oyre S, Pedersen EM, Houlind K, Guenet FS, Yoganathan AP. A new control volume method for calculating valvular regurgitation Circulation 1995;92:579-586.
327. Hundley WG, Li HF, Willard JE, et al. Magnetic resonance imaging assessment of the severity of mitral regurgitation: comparison with invasive techniques Circulation 1995;92:1151-1158.
328. Bonow RO, Nikas D, Elefteriades JA. Valve replacement for regurgitant lesions of the aortic or mitral valve in advanced left ventricular dysfunction Cardiol Clin 1995;13:73-8385.
329. Rahimtoola SH. Valve replacement should not be performed in all asymptomatic patients with severe aortic incompetence J Thorac Cardiovasc Surg 1980;79:163-172.
330. Nishimura RA, McGoon, MD, Schaff HV, Giuliani ER. Chronic aortic regurgitation: indications for operation—1988 Mayo Clin Proc 1988;63:270-280.
331. Carabello BA. The changing unnatural history of valvular regurgitation Ann Thorac Surg 1992;53:191-199.
332. Gaasch WH, Sundaram M, Meyer TE. Managing asymptomatic patients with chronic aortic regurgitation Chest 1997;111:1702-1709.
333. Bonow RO. Chronic aortic regurgitation: role of medical therapy and optimal timing for surgery Cardiol Clin 1998;16:449-461.
334. Borer JS, Bonow RO. Contemporary approach to aortic and mitral regurgitation Circulation 2003;108:2432-2438.
335. Enriquez-Sarano M, Tajik AJ. Clinical practice: aortic regurgitation N Engl J Med 2004;351:1539-1546.
336. Turina J, Turina M, Rothlin M, Krayenbuehl HP. Improved late survival in patients with chronic aortic regurgitation by earlier operation Circulation 1984;70:I147-I152.
337. Gaasch WH, Schick EC. Symptoms and left ventricular size and function in patients with chronic aortic regurgitation J Am Coll Cardiol 2003;41:1325-1328.
338. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Surgery for aortic regurgitation in women: contrasting indications and outcomes compared with men Circulation 1996;94:2472-2478.
339. Mathew RK, Gaasch WH, Guilmette NE, Schick EC, Labib SB. Anthropometric normalization of left ventricular size in chronic mitral regurgitation Am J Cardiol 2003;91:762-764.
340. Vasan RS, Larson MG, Levy D, Evans JC, Benjamin EJ. Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation Circulation 1997;96:1863-1873.
341. Gash AK, Carabello BA, Kent RL, Frazier JA, Spann JF. Left ventricular performance in patients with coexistent mitral stenosis and aortic insufficiency J Am Coll Cardiol 1984;3:703-711.
342. Olson LJ, Subramanian R, Edwards WD. Surgical pathology of pure aortic insufficiency: a study of 225 cases Mayo Clin Proc 1984;59:835-841.
343. Lindsay Jr J, Beall Jr AC, DeBakey ME. Diagnosis and treatment of diseases of the aortaIn: Schlant R, Alexander RW, editors. Hurst's The Heart. 9th edition. New York, NY: McGraw Hill; 1998. pp. 2461-2482.
344. Ergin MA, Spielvogel D, Apaydin A, et al. Surgical treatment of the dilated ascending aorta: when and how? Ann Thorac Surg 1999;67:1834-1839.
345. Boucher CA, Bingham JB, Osbakken, MD, et al. Early changes in left ventricular size and function after correction of left ventricular volume overload Am J Cardiol 1981;47:991-1004.
346. Schuler G, Peterson KL, Johnson AD, et al. Serial noninvasive assessment of left ventricular hypertrophy and function after surgical correction of aortic regurgitation Am J Cardiol 1979;44:585-594.
347. Elayda MA, Hall RJ, Reul RM, et al. Aortic valve replacement in patients 80 years and older: operative risks and long-term results Circulation 1993 ;88:II11 -II16.
348. Nataatmadja M, West M, West J, et al. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in Marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm Circulation 2003;108(Suppl 1):II329-II334.
349. Braverman AC, Guven H, Beardslee MA, Makan M, Kates AM, Moon MR. The bicuspid aortic valve Curr Probl Cardiol 2005;30:470-522.
350. Hahn RT, Roman MJ, Mogtader AH, Devereux RB. Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves J Am Coll Cardiol 1992;19:283-
288.
351. Nistri S, Sorbo, MD, Marin M, Palisi M, Scognamiglio R, Thiene G. Aortic root dilatation in young men with normally functioning bicuspid aortic valves Heart 1999;82:19-22.
352. Keane MG, Wiegers SE, Plappert T, Pochettino A, Bavaria JE, Sutton MG. Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions Circulation 2000;102:III35-III39.
353. Fedak PW, Verma S, David TE, Leask RL, Weisel RD, Butany J. Clinical and pathophysiological implications of a bicuspid aortic valve Circulation 2002;106:900-904.
354. Ferencik M, Pape LA. Changes in size of ascending aorta and aortic valve function with time in patients with congenitally bicuspid aortic valves Am J Cardiol 2003;92:43-46.
355. Roberts CS, Roberts WC. Dissection of the aorta associated with congenital malformation of the aortic valve J Am Coll Cardiol 1991;17:712-716.
356. Davies RR, Goldstein LJ, Coady MA, et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size Ann Thorac Surg 2002;73:17-27.
357. Svensson LG, Kim KH, Lytle BW, Cosgrove DM. Relationship of aortic cross-sectional area to height ratio and the risk of aortic dissection in patients with bicuspid aortic valves J Thorac Cardiovasc Surg 2003;126:892-893.
358. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks Ann Thorac Surg 2002;74:S1877-S1880.
359. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome N Engl J Med 1994;330:1335-1341.
360. Roman MJ, Devereux RB, Kramer-Fox R, O'Loughlin J. Two-dimensional echocardiographic aortic root dimensions in normal children and adults Am J Cardiol 1989;64:507-
512.
361. Johnston KW, Rutherford RB, Tilson, MD, Shah DM, Hollier L, Stanley JC. Suggested standards for reporting on arterial aneurysms: Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery J Vasc Surg 1991;13:452-458.
362. David TE, Armstrong S, Ivanov J, Webb GD. Aortic valve sparing operations: an update Ann Thorac Surg 1999;67:1840-1842.
363. Kallenbach K, Hagl C, Walles T, et al. Results of valve-sparing aortic root reconstruction in 158 consecutive patients Ann Thorac Surg 2002;74:2026-2032.
364. Zehr KJ, Orszulak TA, Mullany CJ, et al. Surgery for aneurysms of the aortic root: a 30-year experience Circulation 2004;110:1364-1371.
365. McDonald ML, Smedira NG, Blackstone EH, Grimm RA, Lytle BW, Cosgrove DM. Reduced survival in women after valve surgery for aortic regurgitation: effect of aortic enlargement and late aortic rupture J Thorac Cardiovasc Surg 2000;119:1205-1212.
366. Borger MA, Preston M, Ivanov J, et al. Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? J Thorac Cardiovasc Surg 2004;128:677-
683.
367. Wood P. An appreciation of mitral stenosis, I: clinical features Br Med J 1954;4870:1051-1063.
368. Rowe JC, Bland EF, Sprague HB, White PD. The course of mitral stenosis without surgery: ten- and twenty-year perspectives Ann Intern Med 1960;52:741-749.
369. Olesen KH. The natural history of 271 patients with mitral stenosis under medical treatment Br Heart J 1962;24:349-357.
370. Roberts WC, Perloff JK. Mitral valvular disease: a clinicopathologic survey of the conditions causing the mitral valve to function abnormally Ann Intern Med 1972;77:939-975.
371. Rusted IE, Scheifley CH, Edwards JE. Studies of the mitral valve, II: certain anatomic features of the mitral valve and associated structures in mitral stenosis Circulation 1956;14:398-
406.
372. Braunwald E, Moscovitz HL, Mram SS, et al. The hemodynamics of the left side of the heart as studied by simultaneous left atrial, left ventricular, and aortic pressures; particular reference to mitral stenosis Circulation 1955;12:69-81.
373. Snopek G, Pogorzelska H, Rywik TM, Browarek A, Janas J, Korewicki J. Usefulness of endothelin-1 concentration in capillary blood in patients with mitral stenosis as a predictor of regression of pulmonary hypertension after mitral valve replacement or valvuloplasty Am J Cardiol 2002;90:188-189.
374. Hugenholtz PG, Ryan TJ, Stein SW, Belmann WH. The spectrum of pure mitral stenosis: hemodynamic studies in relation to clinical disability Am J Cardiol 1962;10:773-784.
375. Kasalicky J, Hurych J, Widimsky J, Dejdar R, Metys R, Stanek V. Left heart haemodynamics at rest and during exercise in patients with mitral stenosis Br Heart J 1968;30:188-
195.
376. Gorlin R. The mechanism of the signs and symptoms of mitral valve disease Br Heart J 1954;16:375-380.
377. Wood P. An appreciation of mitral stenosis, II: investigations and results Br Med J 1954;4871:1113-1124.
378. Halperin JL, Brooks KM, Rothlauf EB, Mindich BP, Ambrose JA, Teichholz LE. Effect of nitroglycerin on the pulmonary venous gradient in patients after mitral valve replacement J Am Coll Cardiol 1985;5:34-39.
379. Halperin JL, Rothlauf EB, Brooks KM, Mindich BP, Ambrose JA. Effect of nitroglycerin during hemodynamic estimation of valve orifice in patients with mitral stenosis J Am Coll Cardiol 1987;10:342-348.
380. Selzer A, Cohn KE. Natural history of mitral stenosis: a review Circulation 1972;45:878-
890.
381. Munoz S, Gallardo J, Diaz-Gorrin JR, Medina O. Influence of surgery on the natural history of rheumatic mitral and aortic valve disease Am J Cardiol 1975;35:234-242.
382. Ward C, Hancock BW. Extreme pulmonary hypertension caused by mitral valve disease: natural history and results of surgery Br Heart J 1975;37:74-78.
383. Carroll JD, Feldman T. Percutaneous mitral balloon valvotomy and the new demographics of mitral stenosis JAMA 1993;270:1731-1736.
384. Tuzcu EM, Block PC, Griffin BP, Newell JB, Palacios IF. Immediate and long-term outcome of percutaneous mitral valvotomy in patients 65 years and older Circulation 1992;85:963-
971.
385. Dubin AA, March HW, Cohn K, Selzer A. Longitudinal hemodynamic and clinical study of mitral stenosis Circulation 1971;44:381-389.
386. Gordon SP, Douglas PS, Come PC, Manning WJ. Two-dimensional and Doppler echocardiographic determinants of the natural history of mitral valve narrowing in patients with rheumatic mitral stenosis: implications for follow-up J Am Coll Cardiol 1992;19:968-973.
387. Craige E. Phonocardiographic studies in mitral stenosis N Engl J Med 1957;257:650-
654.
388. Henry WL, Griffith JM, Michaelis LL, McIntosh CL, Morrow AG, Epstein SE. Measurement of mitral orifice area in patients with mitral valve disease by real-time, twodimensional echocardiography Circulation 1975;51:827-831.
389. Holen J, Aaslid R, Landmark K, Simonsen S. Determination of pressure gradient in mitral stenosis with a non-invasive ultrasound Doppler technique Acta Med Scand 1976;199:455-
460.
390. Nichol PM, Gilbert BW, Kisslo JA. Two-dimensional echocardiographic assessment of mitral stenosis Circulation 1977;55:120-128.
391. Hatle L, Brubakk A, Tromsdal A, Angelsen B. Noninvasive assessment of pressure drop in mitral stenosis by Doppler ultrasound Br Heart J 1978;40:131 -140.
392. Wann LS, Weyman AE, Feigenbaum H, Dillon JC, Johnston KW, Eggleton RC. Determination of mitral valve area by cross-sectional echocardiography Ann Intern Med 1978;88:337-341.
393. Martin RP, Rakowski H, Kleiman JH, Beaver W, London E, Popp RL. Reliability and reproducibility of two dimensional echocardiograph measurement of the stenotic mitral valve orifice area Am J Cardiol 1979;43:560-568.
394. Reid CL, McKay CR, Chandraratna PA, Kawanishi DT, Rahimtoola SH. Mechanisms of increase in mitral valve area and influence of anatomic features in double-balloon, catheter balloon valvuloplasty in adults with rheumatic mitral stenosis: a Doppler and two-dimensional echocardiographic study Circulation 1987;76:628-636.
395. Rediker DE, Block PC, Abascal VM, Palacios IF. Mitral balloon valvuloplasty for mitral restenosis after surgical commissurotomy J Am Coll Cardiol 1988;11:252-256.
396. Fatkin D, Roy P, Morgan JJ, Feneley MP. Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome J Am Coll Cardiol 1993;21:390-397.
397. Iung B, Cormier B, Ducimetiere P, et al. Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors J Am Coll Cardiol 1996;27:407-414.
398. Cannan CR, Nishimura RA, Reeder GS, et al. Echocardiographic assessment of commissural calcium: a simple predictor of outcome after percutaneous mitral balloon valvotomy J Am Coll Cardiol 1997;29:175-180.
399. Reid CL, Chandraratna PA, Kawanishi DT, Kotlewski A, Rahimtoola SH. Influence of mitral valve morphology on double-balloon catheter balloon valvuloplasty in patients with mitral stenosis: analysis of factors predicting immediate and 3-month results Circulation 1989;80:515-524.
400. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation Br Heart J 1988;60:299-308.
401. Hatle L, Angelsen B, Tromsdal A. Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound Circulation 1979;60:1096-1104.
402. Nakatani S, Masuyama T, Kodama K, Kitabatake A, Fujii K, Kamada T. Value and limitations of Doppler echocardiography in the quantification of stenotic mitral valve area: comparison of the pressure half-time and the continuity equation methods Circulation 1988;77:78-
85.
403. Thomas JD, Wilkins GT, Choong CY, et al. Inaccuracy of mitral pressure half-time immediately after percutaneous mitral valvotomy. Dependence on transmitral gradient and left atrial and ventricular compliance. Circulation 1988;78:980-993.
404. Flachskampf FA, Weyman AE, Guerrero JL, Thomas JD. Influence of orifice geometry and flow rate on effective valve area: an in vitro study J Am Coll Cardiol 1990; 15:1173-1180.
405. Currie PJ, Seward JB, Chan KL, et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients J Am Coll Cardiol 1985;6:750-756.
406. Himelman RB, Stulbarg M, Kircher B, et al. Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease Circulation 1989;79:863-871.
407. Tamai J, Nagata S, Akaike M, et al. Improvement in mitral flow dynamics during exercise after percutaneous transvenous mitral commissurotomy: noninvasive evaluation using continuous wave Doppler technique Circulation 1990;81:46-51.
408. Leavitt JI, Coats MH, Falk RH. Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve: a Doppler echocardiographic study J Am Coll Cardiol 1991;17:1520-1526.
409. Cheriex EC, Pieters FA, Janssen JH, de Swart H, Palmans-Meulemans A. Value of exercise Doppler-echocardiography in patients with mitral stenosis Int J Cardiol 1994;45:219-226.
410. Okay T, Deligonul U, Sancaktar O, Kozan O. Contribution of mitral valve reserve capacity to sustained symptomatic improvement after balloon valvulotomy in mitral stenosis: implications for restenosis J Am Coll Cardiol 1993;22:1691-1696.
411. Nakhjavan FK, Katz MR, Maranhao V, Goldberg H. Analysis of influence of catecholamine and tachycardia during supine exercise in patients with mitral stenosis and sinus rhythm Br Heart J 1969;31:753-761.
412. Bhatia ML, Shrivastava S, Roy SB. Immediate haemodynamic effects of a beta adrenergic blocking agent—propranolo—in mitral stenosis at fixed heart rates Br Heart J 1972;34638-4.
413. Alan S, Ulgen MS, Ozdemir K, Keles T, Toprak N. Reliability and efficacy of metoprolol and diltiazem in patients having mild to moderate mitral stenosis with sinus rhythm Angiology 2002;53:575-581.
414. Cieslewicz G, Juszczyk G, Foremny J, et al. Inhaled corticosteroid improves bronchial reactivity and decreases symptoms in patients with mitral stenosis Chest 1998;114:1070-1074.
415. Beiser GD, Epstein SE, Stampfer M, Robinson B, Braunwald E. Studies on digitalis, XVII: effects of ouabain on the hemodynamic response to exercise in patients with mitral stenosis in normal sinus rhythm N Engl J Med 1968;278:131-137.
416. Coulshed N, Epstein EJ, McKendrick CS, Galloway RW, Walker E. Systemic embolism in mitral valve disease Br Heart J 1970;32:26-34.
417. Abernathy WS, Willis III PW. Thromboembolic complications of rheumatic heart disease Cardiovasc Clin 1973;5:131-175.
418. Daley R, Mattingly TW, Holt CL, Bland EF, White PD. Systemic arterial embolism in rheumatic heart disease Am Heart J 1951;42:566-581.
419. Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotic therapy in atrial fibrillation Chest 1992;102:426S-433S.
420. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study J Am Coll Cardiol 1995;25:1354-1361.
421. Adams GF, Merrett JD, Hutchinson WM, Pollock AM. Cerebral embolism and mitral stenosis: survival with and without anticoagulants J Neurol Neurosurg Psych 1974;37:378-383.
422. Krasuski RA, Assar, MD, Wang A, et al. Usefulness of percutaneous balloon mitral commissurotomy in preventing the development of atrial fibrillation in patients with mitral stenosis Am J Cardiol 2004;93:936-939.
423. Levine HJ, Pauker SG, Eckman MH. Antithrombotic therapy in valvular heart disease Chest 1995;108:360S-370S.
424. Caplan LR, D'Cruz I, Hier DB, Reddy H, Shah S. Atrial size, atrial fibrillation, and stroke Ann Neurol 1986;19:158-161.
425. Stroke Prevention in Atrial Fibrillation Study: final results Circulation 1991;84:527-539.
426. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation: Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators N Engl J Med 1992;327:1406-1412.
427. Gohlke-Barwolf C, Acar J, Oakley C, et al. Guidelines for prevention of thromboembolic events in valvular heart disease: Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology Eur Heart J 1995;16:1320-1330.
428. Kellogg F, Liu CK, Fishman IW, Larson R. Systemic and pulmonary emboli before and after mitral commissurotomy Circulation 1961;24:263-266.
429. Deverall PB, Olley PM, Smith DR, Watson DA, Whitaker W. Incidence of systemic embolism before and after mitral valvotomy Thorax 1968;23:530-536.
430. Chiang CW, Lo SK, Ko YS, Cheng NJ, Lin PJ, Chang CH. Predictors of systemic embolism in patients with mitral stenosis: a prospective study Ann Intern Med 1998;128:885-889.
431. Gorlin R, Sawyer CG, Haynes FW, Goodale WT, Dexter L. Effects of exercise on circulatory dynamics in mitral stenosis, III Am Heart J 1951;41:192-203.
432. Harvey RM, Ferrer I, Samet P, et al. Mechanical and myocardial factors in rheumatic heart disease with mitral stenosis Circulation 1955;11:531-551.
433. Aviles RJ, Nishimura RA, Pellikka PA, Andreen KM, Holmes Jr DR. Utility of stress Doppler echocardiography in patients undergoing percutaneous mitral balloon valvotomy J Am Soc Echocardiogr 2001;14:676-681.
434. Nishimura RA, Rihal CS, Tajik AJ, Holmes Jr DR. Accurate measurement of the transmitral gradient in patients with mitral stenosis: a simultaneous catheterization and Doppler echocardiographic study J Am Coll Cardiol 1994;24:152-158.
435. Dahl JC, Winchell P, Borden CW. Mitral stenosis: a long term postoperative follow-up Arch Intern Med 1967;119:92-97.
436. Ellis LB, Singh JB, Morales DD, Harken DE. Fifteen- to twenty-year study of one thousand patients undergoing closed mitral valvuloplasty Circulation 1973;48:357-364.
437. John S, Bashi VV, Jairaj PS, et al. Closed mitral valvotomy: early results and long-term follow-up of 3724 consecutive patients Circulation 1983;68:891-896.
438. Finnegan JO, Gray DC, MacVaugh III H, Joyner CR, Johnson J. The open approach to mitral commissurotomy J Thorac Cardiovasc Surg 1974;67:75-82.
439. Mullin MJ, Engelman RM, Isom OW, Boyd AD, Glassman E, Spencer FC. Experience with open mitral commissurotomy in 100 consecutive patients Surgery 1974;76:974-982.
440. Halseth WL, Elliott DP, Walker EL, Smith EA. Open mitral commissurotomy: a modern re-evaluation J Thorac Cardiovasc Surg 1980;80:842-848.
441. Gross RI, Cunningham Jr JN, Snively SL, et al. Long-term results of open radical mitral commissurotomy: ten year follow-up study of 202 patients Am J Cardiol 1981;47:821-825.
442. Garcia-Fernandez MA, Perez-David E, Quiles J, et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study J Am Coll Cardiol 2003;42:1253-1258.
443. Cribier A, Eltchaninoff H, Koning R, et al. Percutaneous mechanical mitral commissurotomy with a newly designed metallic valvulotome: immediate results of the initial experience in 153 patients Circulation 1999;99:793-799.
444. Multicenter experience with balloon mitral commissurotomy: NHLBI Balloon Valvuloplasty Registry Report on immediate and 30-day follow-up results: the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry Participants Circulation 1992;85:448-
461.
445. Feldman T. Hemodynamic results, clinical outcome, and complications of Inoue balloon mitral valvotomy Cathet Cardiovasc Diagn 1994;85(Suppl 2):2-7.
446. Cohen DJ, Kuntz RE, Gordon SP, et al. Predictors of long-term outcome after percutaneous balloon mitral valvuloplasty N Engl J Med 1992;327:1329-1335.
447. Complications and mortality of percutaneous balloon mitral commissurotomy: a report from the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry Circulation 1992;85:2014-2024.
448. Orrange SE, Kawanishi DT, Lopez BM, Curry SM, Rahimtoola SH. Actuarial outcome after catheter balloon commissurotomy in patients with mitral stenosis Circulation 1997;95:382-
389.
449. Dean LS, Mickel M, Bonan R, et al. Four-year follow-up of patients undergoing percutaneous balloon mitral commissurotomy: a report from the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry J Am Coll Cardiol 1996;28:1452-1457.
450. Iung B, Garbarz E, Michaud P, et al. Late results of percutaneous mitral commissurotomy in a series of 1024 patients: analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors Circulation 1999;99:3272-3278.
451. Kang DH, Park SW, Song JK, et al. Long-term clinical and echocardiographic outcome of percutaneous mitral valvuloplasty: randomized comparison of Inoue and double-balloon techniques J Am Coll Cardiol 2000;35169-5.
452. Tokmakoglu H, Vural KM, Ozatik MA, Cehreli S, Sener E, Tasdemir O. Closed commissurotomy versus balloon valvuloplasty for rheumatic mitral stenosis J Heart Valve Dis 2001;10:281-287.
453. Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block PC. Which patients benefit from percutaneous mitral balloon valvuloplasty?. Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation 2002;105:1465-1471.
454. Palacios IF, Tuzcu ME, Weyman AE, Newell JB, Block PC. Clinical follow-up of patients undergoing percutaneous mitral balloon valvotomy Circulation 1995;91:671-676.
455. Hernandez R, Banuelos C, Alfonso F, et al. Long-term clinical and echocardiographic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon Circulation 1999;99:1580-1586.
456. Patel JJ, Shama D, Mitha AS, et al. Balloon valvuloplasty versus closed commissurotomy for pliable mitral stenosis: a prospective hemodynamic study J Am Coll Cardiol 1991;18:1318-1322.
457. Turi ZG, Reyes VP, Raju BS, et al. Percutaneous balloon versus surgical closed commissurotomy for mitral stenosis: a prospective, randomized trial Circulation 1991 ;83: 11791185.
458. Arora R, Nair M, Kalra GS, Nigam M, Khalilullah M. Immediate and long-term results of balloon and surgical closed mitral valvotomy: a randomized comparative study Am Heart J 1993;125:1091-1094.
459. Reyes VP, Raju BS, Wynne J, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis N Engl J Med 1994;331:961-967.
460. Ben Farhat M, Ayari M, Maatouk F, et al. Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow-up results of a randomized trial Circulation 1998;97:245-250.
461. Cotrufo M, Renzulli A, Ismeno G, et al. Percutaneous mitral commissurotomy versus open mitral commissurotomy: a comparative study Eur J Cardiothorac Surg 1999;15:646-651.
462. Padial LR, Freitas N, Sagie A, et al. Echocardiography can predict which patients will develop severe mitral regurgitation after percutaneous mitral valvulotomy J Am Coll Cardiol 1996;27:1225-1231.
463. Silaruks S, Thinkhamrop B, Tantikosum W, Wongvipaporn C, Tatsanavivat P, Klungboonkrong V. A prognostic model for predicting the disappearance of left atrial thrombi among candidates for percutaneous transvenous mitral commissurotomy J Am Coll Cardiol 2002;39:886-891.
464. Padial LR, Abascal VM, Moreno PR, Weyman AE, Levine RA, Palacios IF. Echocardiography can predict the development of severe mitral regurgitation after percutaneous mitral valvuloplasty by the Inoue technique Am J Cardiol 1999;83:1210-1213.
465. Post JR, Feldman T, Isner J, Herrmann HC. Inoue balloon mitral valvotomy in patients with severe valvular and subvalvular deformity J Am Coll Cardiol 1995;25:1129-1136.
466. Wu ZK, Sun PW, Zhang X, Zhong FT, Tong CW, Lu K. Superiority of mitral valve replacement with preservation of subvalvular structure to conventional replacement in severe rheumatic mitral valve disease: a modified technique and results of one-year follow up J Heart Valve Dis 2000;9:616-622.
467. David TE. Artificial chordae Semin Thorac Cardiovasc Surg 2004;16:161-168.
468. Privitera S, Butany J, Silversides C, Leask RL, David TE. Artificial chordae tendinae: long-term changes J Card Surg 2005;20:90-92.
469. Yasu T, Katsuki T, Ohmura N, et al. Delayed improvement in skeletal muscle metabolism and exercise capacity in patients with mitral stenosis following immediate hemodynamic amelioration by percutaneous transvenous mitral commissurotomy Am J Cardiol 1996;77:492-497.
470. Braunwald E, Braunwald NS, Ross JJ, Morrow AG. Effects of mitral valve replacement on the pulmonary vascular dynamics of patients with pulmonary hypertension N Engl J Med 1965;273509-7.
471. Dalen JE, Matloff JM, Evans GL, et al. Early reduction of pulmonary vascular resistance after mitral-valve replacement N Engl J Med 1967;277:387-394.
472. McKay CR, Kawanishi DT, Kotlewski A, et al. Improvement in exercise capacity and exercise hemodynamics 3 months after double-balloon, catheter balloon valvuloplasty treatment of patients with symptomatic mitral stenosis Circulation 1988;77:1013-1021.
473. Rihal CS, Schaff HV, Frye RL, Bailey KR, Hammes LN, Holmes Jr DR. Long-term follow-up of patients undergoing closed transventricular mitral commissurotomy: a useful surrogate for percutaneous balloon mitral valvuloplasty? J Am Coll Cardiol 1992;20:781-786.
474. Mahoney PD, Loh E, Blitz LR, Herrmann HC. Hemodynamic effects of inhaled nitric oxide in women with mitral stenosis and pulmonary hypertension Am J Cardiol 2001;87:188-192.
475. Higgs LM, Glancy DL, O'Brien KP, Epstein SE, Morrow AG. Mitral restenosis: an uncommon cause of recurrent symptoms following mitral commissurotomy Am J Cardiol 1970;26:34-37.
476. Abascal VM, Wilkins GT, Choong CY, et al. Echocardiographic evaluation of mitral valve structure and function in patients followed for at least 6 months after percutaneous balloon mitral valvuloplasty J Am Coll Cardiol 1988;12:606-615.
477. Jang IK, Block PC, Newell JB, Tuzcu EM, Palacios IF. Percutaneous mitral balloon valvotomy for recurrent mitral stenosis after surgical commissurotomy Am J Cardiol 1995;75:601-
605.
478. Rangel A, Chavez E, Murillo H, Ayala F. Immediate results of the Inoue mitral valvotomy in patients with previous surgical mitral commissurotomy: preliminary report Arch Med Res 1998;29:159-163.
479. Gupta A, Lokhandwala YY, Satoskar PR, Salvi VS. Balloon mitral valvotomy in pregnancy: maternal and fetal outcomes J Am Coll Surg 1998;187:409-415.
480. Shaw TR, Sutaria N, Prendergast B. Clinical and haemodynamic profiles of young, middle aged, and elderly patients with mitral stenosis undergoing mitral balloon valvotomy Heart 2003;89:1430-1436.
481. Freed LA, Benjamin EJ, Levy D, et al. Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study J Am Coll Cardiol 2002;40:1298-1304.
482. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse N Engl J Med 1999;341:1-7. 483. Lucas Jr RV, Edwards JE. The floppy mitral valve Curr Probl Cardiol 1982;7:1-48.
484. Shell WE, Walton JA, Clifford ME, Willis III PW. The familial occurrence of the syndrome of mid-late systolic click and late systolic murmur Circulation 1969;39:327-337.
485. Devereux RB, Brown WT, Kramer-Fox R, Sachs I. Inheritance of mitral valve prolapse: effect of age and sex on gene expression Ann Intern Med 1982;97:826-832.
486. Disse S, Abergel E, Berrebi A, et al. Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1 Am J Hum Genet 1999;65:1242-1251.
487. Freed LA, Acierno Jr JS, Dai D, et al. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4 Am J Hum Genet 2003;72:1551-1559.
488. Nesta F, Leyne M, Yosefy C, et al. New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies Circulation 2005;112:2022-2030.
489. Leier CV, Call TD, Fulkerson PK, Wooley CF. The spectrum of cardiac defects in the Ehlers-Danlos syndrome, types I and III Ann Intern Med 1980;92:171-178.
490. Schwarz T, Gotsman MS. Mitral valve prolapse in osteogenesis imperfecta Isr J Med Sci 1981;17:1087-1088.
491. Lebwohl MG, Distefano D, Prioleau PG, Uram M, Yannuzzi LA, Fleischmajer R. Pseudoxanthoma elasticum and mitral-valve prolapse N Engl J Med 1982;307:228-231.
492. Rosenberg CA, Derman GH, Grabb WC, Buda AJ. Hypomastia and mitral-valve prolapse: evidence of a linked embryologic and mesenchymal dysplasia N Engl J Med 1983;309:1230-1232.
493. Avierinos JF, Gersh BJ, Melton III LJ, et al. Natural history of asymptomatic mitral valve prolapse in the community Circulation 2002;106:1355-1361.
494. Chandraratna PA, Nimalasuriya A, Kawanishi D, Duncan P, Rosin B, Rahimtoola SH. Identification of the increased frequency of cardiovascular abnormalities associated with mitral valve prolapse by two-dimensional echocardiography Am J Cardiol 1984;54:1283-1285.
495. Nishimura RA, McGoon, MD, Shub C, Miller Jr FA, Ilstrup DM, Tajik AJ. Echocardiographically documented mitral-valve prolapse: long-term follow-up of 237 patients N Engl J Med 1985;313:1305-1309.
496. Marks AR, Choong CY, Sanfilippo AJ, Ferre M, Weyman AE. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse N Engl J Med 1989;320:1031-
1036.
497. Takamoto T, Nitta M, Tsujibayashi T, Taniguchi K, Marumo F. The prevalence and clinical features of pathologically abnormal mitral valve leaflets (myxomatous mitral valve) in the mitral valve prolapse syndrome: an echocardiographic and pathological comparative study J Cardiol Suppl 1991;25:75-86.
498. Babuty D, Cosnay P, Breuillac JC, et al. Ventricular arrhythmia factors in mitral valve prolapse Pacing Clin Electrophysiol 1994;17:1090-1099.
499. Zuppiroli A, Mori F, Favilli S, et al. Arrhythmias in mitral valve prolapse: relation to anterior mitral leaflet thickening, clinical variables, and color Doppler echocardiographic parameters Am Heart J 1994;128:919-927.
500. Allen H, Harris A, Leatham A. Significance and prognosis of an isolated late systolic murmur: a 9- to 22-year follow-up Br Heart J 1974;36:525-532.
501. Mills P, Rose J, Hollingsworth J, Amara I, Craige E. Long-term prognosis of mitral-valve prolapse N Engl J Med 1977;297:13-18.
502. Fontana ME, Sparks EA, Boudoulas H, Wooley CF. Mitral valve prolapse and the mitral valve prolapse syndrome Curr Probl Cardiol 1991;16:309-375.
503. Clemens JD, Horwitz RI, Jaffe CC, Feinstein AR, Stanton BF. A controlled evaluation of the risk of bacterial endocarditis in persons with mitral-valve prolapse N Engl J Med 1982;307:776-
781.
504. Devereux RB, Frary CJ, Kramer-Fox R, Roberts RB, Ruchlin HS. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur Am J Cardiol 1994;74:1024-1029.
505. Wilson LA, Keeling PW, Malcolm AD, Russel RW, Webb-Peploe MM. Visual complications of mitral leaflet prolapse Br Med J 1977;2:86-88.
506. Barnett HJ, Boughner DR, Taylor DW, Cooper PE, Kostuk WJ, Nichol PM. Further evidence relating mitral-valve prolapse to cerebral ischemic events N Engl J Med 1980;302:139-
144.
507. Cheitlin MD, Byrd RC. Prolapsed mitral valve: the commonest valve disease? Curr Probl Cardiol 1984;8:1-54.
508. Devereux RB, Hawkins I, Kramer-Fox R, et al. Complications of mitral valve prolapse: disproportionate occurrence in men and older patients Am J Med 1986;81:751 -758.
509. Duren DR, Becker AE, Dunning AJ. Long-term follow-up of idiopathic mitral valve prolapse in 300 patients: a prospective study J Am Coll Cardiol 1988; 11:42-47.
510. Boudoulas H, Kobash BH, Wooley CF. Mitral valve prolapse: a heterogeneous disorder Primary Cardiology 1991;17:29-43.
511. Zuppiroli A, Rinaldi M, Kramer-Fox R, Favilli S, Roman MJ, Devereux RB. Natural history of mitral valve prolapse Am J Cardiol 1995;75:1028-1032.
512. Vohra J, Sathe S, Warren R, Tatoulis J, Hunt D. Malignant ventricular arrhythmias in patients with mitral valve prolapse and mild mitral regurgitation Pacing Clin Electrophysiol 1993;16:387-393.
513. Martini B, Basso C, Thiene G. Sudden death in mitral valve prolapse with Holter monitoring-documented ventricular fibrillation: evidence of coexisting arrhythmogenic right ventricular cardiomyopathy Int J Cardiol 1995;49:274-278.
514. Puddu PE, Pasternac A, Tubau JF, Krol R, Farley L, de Champlain J. QT interval prolongation and increased plasma catecholamine levels in patients with mitral valve prolapse Am Heart J 1983;105:422-428.
515. O'Rourke RA, Crawford MH. The systolic click-murmur syndrome: clinical recognition and management Curr Probl Cardiol 1976;1:1-60.
516. Shah PM. Echocardiographic diagnosis of mitral valve prolapse J Am Soc Echocardiogr 1994;7:286-293.
517. Krivokapich J, Child JS, Dadourian BJ, Perloff JK. Reassessment of echocardiographic criteria for diagnosis of mitral valve prolapse Am J Cardiol 1988;61:131-135.
518. Ling LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral regurgitation due to flail leaflet N Engl J Med 1996;335:1417-1423.
519. Bankier B, Littman AB. Psychiatric disorders and coronary heart disease in women—a still neglected topic: review of the literature from 1971 to 2000 Psychother Psychosom 2002;71:133-140.
520. Barnett HJ, Jones MW, Boughner DR, Kostuk WJ. Cerebral ischemic events associated with prolapsing mitral valve Arch Neurol 1976;33:777-782.
521. Barletta GA, Gagliardi R, Benvenuti L, Fantini F. Cerebral ischemic attacks as a complication of aortic and mitral valve prolapse Stroke 1985;16219-3.
522. Boughner DR, Barnett HJ. The enigma of the risk of stroke in mitral valve prolapse Stroke 1985;16:175-177.
523. Winkle RA, Lopes MG, Goodman DJ, Fitzgerald JW, Schroeder JS, Harrison DC. Propranolol for patients with mitral valve prolapse Am Heart J 1977;93:422-427.
524. Schaal SF. Ventricular arrhythmias in patients with mitral valve prolapse Cardiovasc Clin 1992;22:307-316.
524. Sacco RL, Adams R, Albers G, et al. Guidelines for the prevention of stroke in patients with ischemic stroke or transient ischemic attacks. A statement for healthcare professionals from the American Heart Association Council on Stroke. Stroke 2006;37:577-617.
525. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study N Engl J Med 1990;322:863-868.
526. Rosen SE, Borer JS, Hochreiter C, et al. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance Am J Cardiol 1994;74:374-380.
527. Engel PJ, Alpert BL, Hickman Jr JR. The nature and prevalence of the abnormal exercise electrocardiogram in mitral valve prolapse Am Heart J 1979;98:716-724.
528. Butman S, Chandraratna PA, Milne N, Olson H, Lyons K, Aronow WS. Stress myocardial imaging in patients with mitral valve prolapse: evidence of a perfusion abnormality Cathet Cardiovasc Diagn 1982;8:243-252.
529. Braunberger E, Deloche A, Berrebi A, et al. Very long-term results (more than 20 years) of valve repair with Carpentier's techniques in nonrheumatic mitral valve insufficiency Circulation 2001; 104:I8-I11.
530. Mohty D, Orszulak TA, Schaff HV, Avierinos JF, Tajik JA, Enriquez-Sarano M. Very long-term survival and durability of mitral valve repair for mitral valve prolapse Circulation 2001;104:I1-I7.
531. Carabello BA. Mitral regurgitation: basic pathophysiologic principles, part 1 Mod Concepts Cardiovasc Dis 1988;57:53-58.
532. Castello R, Fagan Jr L, Lenzen P, Pearson AC, Labovitz AJ. Comparison of transthoracic and transesophageal echocardiography for assessment of left-sided valvular regurgitation Am J Cardiol 1991;68:1677-1680.
533. Connolly MW, Gelbfish JS, Jacobowitz IJ, et al. Surgical results for mitral regurgitation from coronary artery disease J Thorac Cardiovasc Surg 1986;91:379-388.
534. Cohn LH, Couper GS, Kinchla NM, Collins Jr JJ. Decreased operative risk of surgical treatment of mitral regurgitation with or without coronary artery disease J Am Coll Cardiol 1990;16:1575-1578.
535. Yoran C, Yellin EL, Becker RM, Gabbay S, Frater RW, Sonnenblick EH. Mechanism of reduction of mitral regurgitation with vasodilator therapy Am J Cardiol 1979;43:773-777.
536. Chatterjee K, Parmley WW, Swan HJ, Berman G, Forrester J, Marcus HS. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus Circulation 1973;48:684-690.
537. Enriquez-Sarano M, Basmadjian AJ, Rossi A, Bailey KR, Seward JB, Tajik AJ. Progression of mitral regurgitation: a prospective Doppler echocardiographic study J Am Coll Cardiol 1999;34:1137-1144.
538. Zile MR, Gaasch WH, Carroll JD, Levine HJ. Chronic mitral regurgitation: predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress J Am Coll Cardiol 1984;3:235-242.
539. Schuler G, Peterson KL, Johnson A, et al. Temporal response of left ventricular performance to mitral valve surgery Circulation 1979;59:1218-1231.
540. Carabello BA, Nolan SP, McGuire LB. Assessment of preoperative left ventricular function in patients with mitral regurgitation: value of the end-systolic wall stress-end-systolic volume ratio Circulation 1981;64:1212-1217.
541. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation N Engl J Med 2005;352:875-883.
542. Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation Circulation 2006; 113:2238-2244.
543. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications Circulation 1999;99:400-405.
544. Crawford MH, Souchek J, Oprian CA, et al. Determinants of survival and left ventricular performance after mitral valve replacement: Department of Veterans Affairs Cooperative Study on Valvular Heart Disease Circulation 1990;81: 1173-1181.
545. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation: a multivariate analysis Circulation 1995;91:1022-1028.
546. Enriquez-Sarano M, Tribouilloy C. Quantitation of mitral regurgitation: rationale, approach, and interpretation in clinical practice Heart 2002;88(Suppl 4):iv1 -iv3.
547. Simonson JS, Schiller NB. Sonospirometry: a new method for noninvasive estimation of mean right atrial pressure based on two-dimensional echographic measurements of the inferior vena cava during measured inspiration J Am Coll Cardiol 1988; 11:557-564.
548. Carpentier A. Cardiac valve surgery—the "French correction." J Thorac Cardiovasc Surg 1983;86:323-337.
549. Phillips HR, Levine FH, Carter JE, et al. Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction Am J Cardiol 1981;48:647-654.
550. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation Circulation 1994;90:830-837.
551. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications J Am Coll Cardiol 1994;24:1536-1543.
552. Wisenbaugh T, Skudicky D, Sareli P. Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation Circulation 1994;89:191-197.
553. Flemming MA, Oral H, Rothman ED, Briesmiester K, Petrusha JA, Starling MR. Echocardiographic markers for mitral valve surgery to preserve left ventricular performance in mitral regurgitation Am Heart J 2000;140:476-482.
554. Corin WJ, Monrad ES, Murakami T, Nonogi H, Hess OM, Krayenbuehl HP. The relationship of afterload to ejection performance in chronic mitral regurgitation Circulation 1987;76:59-67.
555. Gaasch WH, Zile MR. Left ventricular function after surgical correction of chronic mitral regurgitation Eur Heart J 1991;12(Suppl B):48-51.
556. Host U, Kelbaek H, Hildebrandt P, Skagen K, Aldershvile J. Effect of ramipril on mitral regurgitation secondary to mitral valve prolapse Am J Cardiol 1997;80:655-658.
557. Marcotte F, Honos GN, Walling AD, et al. Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function Can J Cardiol 1997;13:479-485.
558. Tischler MD, Rowan M, LeWinter MM. Effect of enalapril therapy on left ventricular mass and volumes in asymptomatic chronic, severe mitral regurgitation secondary to mitral valve prolapse Am J Cardiol 1998;82:242-245.
559. Dell'Italia LJ, Meng QC, Balcells E, et al. Compartmentalization of angiotensin II generation in the dog heart: evidence for independent mechanisms in intravascular and interstitial spaces J Clin Invest 1997;100:253-258.
560. Capomolla S, Febo O, Gnemmi M, et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol Am Heart J 2000;139:596-
608.
561. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation In Cardiomyopathy (MUSTIC) study J Am Coll Cardiol 2002;40:111-118.
562. Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure J Am Coll Cardiol 2003;41:765-770. 563. St John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure Circulation 2003 ;107:1985-1990.
564. Beppu S, Nimura Y, Sakakibara H, Nagata S, Park YD, Izumi S. Smoke-like echo in the left atrial cavity in mitral valve disease: its features and significance J Am Coll Cardiol 1985;6:744-
749.
565. Blackshear JL, Pearce LA, Asinger RW, et al. Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation: Stroke Prevention in Atrial Fibrillation Investigators Am J Cardiol 1993;72:840-843.
566. Croft CH, Lipscomb K, Mathis K, et al. Limitations of qualitative angiographic grading in aortic or mitral regurgitation Am J Cardiol 1984;53:1593-1598.
567. Fuchs RM, Heuser RR, Yin FC, Brinker JA. Limitations of pulmonary wedge V waves in diagnosing mitral regurgitation Am J Cardiol 1982;49:849-854.
568. Duran CG, Pomar JL, Revuelta JM, et al. Conservative operation for mitral insufficiency: critical analysis supported by postoperative hemodynamic studies of 72 patients J Thorac Cardiovasc Surg 1980;79:326-337.
569. Yacoub M, Halim M, Radley-Smith R, McKay R, Nijveld A, Towers M. Surgical treatment of mitral regurgitation caused by floppy valves: repair versus replacement Circulation 1981;64:II210-II216.
570. David TE, Uden DE, Strauss HD. The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation Circulation 1983;68:II76-II82.
571. Perier P, Deloche A, Chauvaud S, et al. Comparative evaluation of mitral valve repair and replacement with Starr, Bjork, and porcine valve prostheses Circulation 1984;70:I187-I192.
572. Goldman ME, Mora F, Guarino T, Fuster V, Mindich BP. Mitral valvuloplasty is superior to valve replacement for preservation of left ventricular function: an intraoperative twodimensional echocardiographic study J Am Coll Cardiol 1987;10:568-575.
573. Tischler MD, Cooper KA, Rowen M, LeWinter MM. Mitral valve replacement versus mitral valve repair: a Doppler and quantitative stress echocardiographic study Circulation 1994;89:132-137.
574. Rushmer RF. Initial phase of ventricular systole: asynchronous contraction Am J Physiol 1956;184:188-194.
575. Gillinov AM, Cosgrove DM, Lytle BW, et al. Reoperation for failure of mitral valve repair J Thorac Cardiovasc Surg 1997;113:467-473.
576. Gillinov AM, Cosgrove DM, Blackstone EH, et al. Durability of mitral valve repair for degenerative disease J Thorac Cardiovasc Surg 1998;116:734-743.
577. Gillinov AM, Cosgrove DM. Mitral valve repair for degenerative disease J Heart Valve Dis 2002;11(Suppl 1):S15-S20.
578. Mohty D, Enriquez-Sarano M. The long-term outcome of mitral valve repair for mitral valve prolapse Curr Cardiol Rep 2002;4:104-110.
579. David TE, Burns RJ, Bacchus CM, Druck MN. Mitral valve replacement for mitral regurgitation with and without preservation of chordae tendineae J Thorac Cardiovasc Surg 1984;88:718-725.
580. Hennein HA, Swain JA, McIntosh CL, Bonow RO, Stone CD, Clark RE. Comparative assessment of chordal preservation versus chordal resection during mitral valve replacement J Thorac Cardiovasc Surg 1990;99:828-836.
581. Rozich JD, Carabello BA, Usher BW, Kratz JM, Bell AE, Zile MR. Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation: mechanisms for differences in postoperative ejection performance Circulation 1992;86:1718-1726.
582. Horskotte D, Schulte HD, Bircks W, Strauer BE. The effect of chordal preservation on late outcome after mitral valve replacement: a randomized study J Heart Valve Dis 1993;2:150-158.
583. Ling LH, Enriquez-Sarano M, Seward JB, et al. Early surgery in patients with mitral regurgitation due to flail leaflets: a long-term outcome study Circulation 1997;96:1819-1825.
584. Craver JM, Cohen C, Weintraub WS. Case-matched comparison of mitral valve replacement and repair Ann Thorac Surg 1990;49:964-969.
585. Wells FC. Conservation and surgical repair of the mitral valveIn: Wells FC, Shapiro LM, editors. Mitral Valve Disease. London, UK: Butterworths; 1996. pp. 114-134.
586. David TE, Omran A, Armstrong S, Sun Z, Ivanov J. Long-term results of mitral valve repair for myxomatous disease with and without chordal replacement with expanded polytetrafluoroethylene sutures J Thorac Cardiovasc Surg 1998;115:1279-1285.
587. Duran CM. Surgical techniques for the repair of anterior mitral leaflet prolapse J Card Surg 1999;14:471-481.
588. Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems J Thorac Cardiovasc Surg 2001;122:674-681.
589. Burkhart HM, Orszulak TA. Complicated mitral valve repairs Cardiol Rev 2001;9:106-
111.
590. Dreyfus GD, Bahrami T, Alayle N, Mihealainu S, Dubois C, De Lentdecker P. Repair of anterior leaflet prolapse by papillary muscle repositioning: a new surgical option Ann Thorac Surg 2001;71:1464-1470.
591. Alfieri O, Elefteriades JA, Chapolini RJ, et al. Novel suture device for beating-heart mitral leaflet approximation Ann Thorac Surg 2002;74:1488-1493.
592. Feindel CM, Tufail Z, David TE, Ivanov J, Armstrong S. Mitral valve surgery in patients with extensive calcification of the mitral annulus J Thorac Cardiovasc Surg 2003;126:777-782.
593. Savage EB. Use of valve repair: analysis of contemporary United States experience reported to the Society of Thoracic Surgeons National Cardiac Database Ann Thorac Surg 2003;75:820-825.
594. Gaasch WH, John RM, Aurigemma GP. Managing asymptomatic patients with chronic mitral regurgitation Chest 1995;108:842-847.
595. Ross Jr J. The timing of surgery for severe mitral regurgitation N Engl J Med 1996;335:1456-1458.
596. Carabello BA, Crawford Jr FA. Valvular heart disease N Engl J Med 1997;337:32-41.
597. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy J Thorac Cardiovasc Surg 1998;115:381-386.
598. Chen FY, Adams DH, Aranki SF, et al. Mitral valve repair in cardiomyopathy Circulation 1998;98:II124-II127.
599. Bishay ES, McCarthy PM, Cosgrove DM, et al. Mitral valve surgery in patients with severe left ventricular dysfunction Eur J Cardiothorac Surg 2000;17:213-221.
600. Bolling SF. Mitral reconstruction in cardiomyopathy J Heart Valve Dis 2002;11(Suppl 1):S26-S31.
601. Badhwar V, Bolling SF. Mitral valve surgery in the patient with left ventricular dysfunction Semin Thorac Cardiovasc Surg 2002;14:133-136.
602. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction J Am Coll Cardiol 2005;45:381-387.
603. Grigioni F, Avierinos JF, Ling LH, et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome J Am Coll Cardiol 2002;40:84-92.
604. Lim E, Barlow CW, Hosseinpour AR, et al. Influence of atrial fibrillation on outcome following mitral valve repair Circulation 2001;104:I59-I63. 605. Eguchi K, Ohtaki E, Matsumura T, et al. Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation Eur Heart J 2005;26:1866-1872.
606. Betriu A, Chaitman BR, Almazan A. Preoperative determinants of return to sinus rhythm after valve replacement. In: Cohn LH, Gallucci V, editors. Cardiac Bioprosthesis. New York, NY: 1982:184-91.
607. Chua YL, Schaff HV, Orszulak TA, Morris JJ. Outcome of mitral valve repair in patients with preoperative atrial fibrillation: should the maze procedure be combined with mitral valvuloplasty? J Thorac Cardiovasc Surg 1994;107:408-415.
608. Handa N, Schaff HV, Morris JJ, Anderson BJ, Kopecky SL, Enriquez-Sarano M. Outcome of valve repair and the Cox maze procedure for mitral regurgitation and associated atrial fibrillation J Thorac Cardiovasc Surg 1999;118:628-635.
609. Schaff HV, Dearani JA, Daly RC, Orszulak TA, Danielson GK. Cox-Maze procedure for atrial fibrillation: Mayo Clinic experience Semin Thorac Cardiovasc Surg 2000;12:30-37.
610. Cox JL. Intraoperative options for treating atrial fibrillation associated with mitral valve disease J Thorac Cardiovasc Surg 2001;122:212-215.
611. Raanani E, Albage A, David TE, Yau TM, Armstrong S. The efficacy of the Cox/maze procedure combined with mitral valve surgery: a matched control study Eur J Cardiothorac Surg 2001;19:438-442.
612. Kobayashi J, Sasako Y, Bando K, et al. Eight-year experience of combined valve repair for mitral regurgitation and maze procedure J Heart Valve Dis 2002;11:165-171.
613. Abreu Filho CAC, Lisboa LA, Dallan LA. Effectiveness of the maze procedure using cooled-tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease Circulation 2005;112:I20-I25.
614. Bando K, Kasegawa H, Okada Y, et al. Impact of preoperative and postoperative atrial fibrillation on outcome after mitral valvuloplasty for nonischemic mitral regurgitation J Thorac Cardiovasc Surg 2005;129:1032-1040. 615. Akins CW, Hilgenberg AD, Buckley MJ, et al. Mitral valve reconstruction versus replacement for degenerative or ischemic mitral regurgitation Ann Thorac Surg 1994;58:668-675.
616. Otsuji Y, Handschumacher, MD, Schwammenthal E, et al. Insights from threedimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry Circulation 1997;96:1999-2008.
617. Otsuji Y, Gilon D, Jiang L, et al. Restricted diastolic opening of the mitral leaflets in patients with left ventricular dysfunction: evidence for increased valve tethering J Am Coll Cardiol 1998;32:398-404.
618. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study Circulation 2000;102:1400-1406.
619. Kumanohoso T, Otsuji Y, Yoshifuku S, et al. Mechanism of higher incidence of ischemic mitral regurgitation in patients with inferior myocardial infarction: quantitative analysis of left ventricular and mitral valve geometry in 103 patients with prior myocardial infarction J Thorac Cardiovasc Surg 2003;125:135-143.
620. Kwan J, Shiota T, Agler DA, et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time threedimensional echocardiography study Circulation 2003;107:1135-1140.
621. Levine RA. Dynamic mitral regurgitation—more than meets the eye N Engl J Med 2004;351:1681-1684.
622. Schwammenthal E, Levine RA. The non-ischaemic dynamics of ischaemic mitral regurgitation: solving the paradox Eur Heart J 2005;26:1454-1455.
623. Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts Circulation 2005;112:745-758.
624. Prifti E, Bonacchi M, Frati G, et al. Should mild-to-moderate and moderate ischemic mitral regurgitation be corrected in patients with impaired left ventricular function undergoing simultaneous coronary revascularization? J Card Surg 2001;16:473-483.
625. Harris KM, Sundt III TM, Aeppli D, Sharma R, Barzilai B. Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve? Ann Thorac Surg 2002;74:1468-1475.
626. Lam BK, Gillinov AM, Blackstone EH, et al. Importance of moderate ischemic mitral regurgitation Ann Thorac Surg 2005;79:462-470.
627. Schroder JN, Williams ML, Hata JA, et al. Impact of mitral valve regurgitation evaluated by intraoperative transesophageal echocardiography on long-term outcomes after coronary artery bypass grafting Circulation 2005;112:I293-I298.
628. Lamas GA, Mitchell GF, Flaker GC, et al. Clinical significance of mitral regurgitation after acute myocardial infarction: Survival and Ventricular Enlargement Investigators Circulation 1997;96:827-833.
629. Duarte IG, Shen Y, MacDonald MJ, Jones EL, Craver JM, Guyton RA. Treatment of moderate mitral regurgitation and coronary disease by coronary bypass alone: late results Ann Thorac Surg 1999;68:426-430.
630. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment Circulation 2001;103:1759-1764.
631. Bursi F, Enriquez-Sarano M, Nkomo VT, et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation Circulation 2005;111:295-
301.
632. Tolis Jr GA, Korkolis DP, Kopf GS, Elefteriades JA. Revascularization alone (without mitral valve repair) suffices in patients with advanced ischemic cardiomyopathy and mild-to-moderate mitral regurgitation Ann Thorac Surg 2002;74:1476-1480.
633. Byrne JG, Aklog L, Adams DH. Assessment and management of functional or ischaemic mitral regurgitation Lancet 2000;355:1743-1744.
634. Grossi EA, Zakow PK, Sussman M, et al. Late results of mitral valve reconstruction in the elderly Ann Thorac Surg 2000;70:1224-1226.
635. Gangemi JJ, Tribble CG, Ross SD, McPherson JA, Kern JA, Kron IL. Does the additive risk of mitral valve repair in patients with ischemic cardiomyopathy prohibit surgical intervention? Ann Surg 2000;231:710-714.
636. Prifti E, Bonacchi M, Frati G, Giunti G, Babatasi G, Sani G. Ischemic mitral valve regurgitation grade II-III: correction in patients with impaired left ventricular function undergoing simultaneous coronary revascularization J Heart Valve Dis 2001;10:754-762.
637. Gillinov AM, Wierup PN, Blackstone EH, et al. Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg 2001;122:1125-1141.
638. Grossi EA, Goldberg JD, LaPietra A, et al. Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications J Thorac Cardiovasc Surg 2001;122:1107-1124.
639. Adams DH, Filsoufi F, Aklog L. Surgical treatment of the ischemic mitral valve J Heart Valve Dis 2002;11(Suppl 1):S21-S25.
640. Aklog L, Filsoufi F, Flores KQ, et al. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation 2001;104:I68-I75.
641. Gillinov AM, Faber C, Houghtaling PL, et al. Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease J Thorac Cardiovasc Surg 2003;125:1350-1362.
642. Campwala SZ, Bansal RC, Wang N, Razzouk A, Pai RG. Factors affecting regression of mitral regurgitation following isolated coronary artery bypass surgery Eur J Cardiothorac Surg 2005;28:104-108.
643. Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. J Am Coll Cardiol 2000;36:1063-1070. 644. Tavakoli R, Weber A, Vogt P, Brunner HP, Pretre R, Turina M. Surgical management of acute mitral valve regurgitation due to post-infarction papillary muscle rupture J Heart Valve Dis 2002;11:20-25.
645. Edmunds Jr LH. Ischemic mitral regurgitationIn: Edmunds Jr LH, editor. Cardiac Surgery in the Adult. New York, NY: McGraw-Hill Co; 1997. pp. 657-676.
646. Cohn LH, Rizzo RJ, Adams DH, et al. The effect of pathophysiology on the surgical treatment of ischemic mitral regurgitation: operative and late risks of repair versus replacement Eur J Cardiothorac Surg 1995;9:568-574.
647. Lee EM, Porter JN, Shapiro LM, Wells FC. Mitral valve surgery in the elderly J Heart Valve Dis 1997;6:22-31.
648. Sahar G, Abramov D, Erez E, et al. Outcome and risk factors in octogenarians undergoing open-heart surgery J Heart Valve Dis 1999;8:162-166.
649. Nowicki ER, Birkmeyer NJ, Weintraub RW, et al. Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England Ann Thorac Surg 2004;77:1966-1977.
650. Nagendran J, Norris C, Maitland A, Koshal A, Ross DB. Is mitral valve surgery safe in octogenarians? Eur J Cardiothorac Surg 2005;28:83-87.
651. DiGregorio V, Zehr KJ, Orszulak TA, et al. Results of mitral surgery in octogenarians with isolated nonrheumatic mitral regurgitation Ann Thorac Surg 2004;78:807-813.
652. Burwash IG, Thomas DD, Sadahiro M, et al. Dependence of Gorlin formula and continuity equation valve areas on transvalvular volume flow rate in valvular aortic stenosis Circulation 1994;89:827-835.
653. Lorell DH, Grossman W. Dynamic and isometric exercise during cardiac catheterizationIn: Baim DS, Grossman W, editors. Cardiac Catheterization Angiography and Intervention. Baltimore, MD: Williams and Wilkins; 1996. pp. 281-296.
654. Sheehan FH, Mitten-Lewis S. Factors influencing accuracy in left ventricular volume determination Am J Cardiol 1989;64:661-664.
655. Fawzy ME, Mimish L, Sivanandam V, et al. Immediate and long-term effect of mitral balloon valvotomy on severe pulmonary hypertension in patients with mitral stenosis Am Heart J 1996;131:89-93.
656. Skudicky D, Essop MR, Sareli P. Efficacy of mitral balloon valvotomy in reducing the severity of associated tricuspid valve regurgitation Am J Cardiol 1994;73:209-211.
657. Duran CM. Tricuspid valve surgery revisited J Card Surg 1994;9:242-247.
658. McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and risk factors for failure J Thorac Cardiovasc Surg 2004;127:674-675.
659. Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg 2005;79:127-132.
660. Fukuda S, Song JM, Gillinov AM, et al. Tricuspid valve tethering predicts residual tricuspid regurgitation after tricuspid annuloplasty Circulation 2005;111:975-979.
661. Gillinov AM, Blackstone EH, Cosgrove III DM, et al. Mitral valve repair with aortic valve replacement is superior to double valve replacement J Thorac Cardiovasc Surg 2003;125:1372-1387.
662. Waller BF, Moriarty AT, Eble JN, Davey DM, Hawley DA, Pless JE. Etiology of pure tricuspid regurgitation based on anular circumference and leaflet area: analysis of 45 necropsy patients with clinical and morphologic evidence of pure tricuspid regurgitation J Am Coll Cardiol 1986;7:1063-1074.
663. Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation—part III Clin Cardiol 1995;18:225-230.
664. Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation—part I Clin Cardiol 1995;18:97-102.
665. Wooley CF, Fontana ME, Kilman JW, Ryan JM. Tricuspid stenosis: atrial systolic murmur, tricuspid opening snap, and right atrial pressure pulse Am J Med 1985;78:375-384.
666. Naylor CD. Systolic propulsion of the eyeballs in tricuspid regurgitation Lancet 1995;346:1706-1784.
667. Hollins GW, Engeset J. Pulsatile varicose veins associated with tricuspid regurgitation Br J Surg 1989;76:207-284.
668. Amidi M, Irwin JM, Salerni R, et al. Venous systolic thrill and murmur in the neck: a consequence of severe tricuspid insufficiency J Am Coll Cardiol 1986;7:942-945.
669. Rivera JM, Vandervoort PM, Vazquez de Prada JA, et al. Which physical factors determine tricuspid regurgitation jet area in the clinical setting? Am J Cardiol 1993;72:1305-1309.
670. Yada I, Tani K, Shimono T, Shikano K, Okabe M, Kusagawa M. Preoperative evaluation and surgical treatment for tricuspid regurgitation associated with acquired valvular heart disease: the Kay-Boyd method vs the Carpentier-Edwards ring method J Cardiovasc Surg (Torino) 1990;31:771-777.
671. Pellegrini A, Colombo T, Donatelli F, et al. Evaluation and treatment of secondary tricuspid insufficiency Eur J Cardiothorac Surg 1992;6:288-296.
672. De Simone R, Lange R, Tanzeem A, Gams E, Hagl S. Adjustable tricuspid valve annuloplasty assisted by intraoperative transesophageal color Doppler echocardiography Am J Cardiol 1993;71:926-931.
673. Kratz J. Evaluation and management of tricuspid valve disease Cardiol Clin 1991;9:397-
407.
674. Orbe LC, Sobrino N, Arcas R, et al. Initial outcome of percutaneous balloon valvuloplasty in rheumatic tricuspid valve stenosis Am J Cardiol 1993;71:353-354.
675. Onate A, Alcibar J, Inguanzo R, Pena N, Gochi R. Balloon dilation of tricuspid and pulmonary valves in carcinoid heart disease Tex Heart Inst J 1993;20:115-119.
676. Sagie A, Schwammenthal E, Newell JB, et al. Significant tricuspid regurgitation is a marker for adverse outcome in patients undergoing percutaneous balloon mitral valvuloplasty J Am Coll Cardiol 1994;24:696-702.
677. Lange R, De Simone R, Bauernschmitt R, Tanzeem A, Schmidt C, Hagl S. Tricuspid valve reconstruction, a treatment option in acute endocarditis Eur J Cardiothorac Surg 1996;10:320-
326.
678. Sutlic Z, Schmid C, Borst HG. Repair of flail anterior leaflets of tricuspid and mitral valves by cusp remodeling Ann Thorac Surg 1990;50:927-930.
679. Choi JB, Kim HK, Yoon HS, Jeong JW. Partial annular plication for atrioventricular valve regurgitation Ann Thorac Surg 1995;59:891-895.
680. De Paulis R, Bobbio M, Ottino G, et al. The De Vega tricuspid annuloplasty: perioperative mortality and long term follow-up J Cardiovasc Surg (Torino) 1990;31:512-517.
681. Minale C, Lambertz H, Nikol S, Gerich N, Messmer BJ. Selective annuloplasty of the tricuspid valve: two-year experience J Thorac Cardiovasc Surg 1990;99:846-851.
682. Aoyagi S, Tanaka K, Hara H, et al. Modified De Vega's annuloplasty for functional tricuspid regurgitation—early and late results Kurume Med J 1992;39:23-32.
683. Holper K, Haehnel JC, Augustin N, Sebening F. Surgery for tricuspid insufficiency: long-term follow-up after De Vega annuloplasty Thorac Cardiovasc Surg 1993;41:1-8.
684. Peltola T, Lepojarvi M, Ikaheimo M, Karkola P. De Vega's annuloplasty for tricuspid regurgitation Ann Chir Gynaecol 1996;85:40-43.
685. Scully HE, Armstrong CS. Tricuspid valve replacement: fifteen years of experience with mechanical prostheses and bioprostheses J Thorac Cardiovasc Surg 1995;109:1035-1041.
686. Connolly HM, Crary JL, McGoon, MD, et al. Valvular heart disease associated with fenfluramine-phentermine N Engl J Med 1997;337:581-588.
687. Graham DJ, Green L. Further cases of valvular heart disease associated with fenfluramine-phentermine N Engl J Med 1997;337:635-638.
688. Langreth R, Johannes L. Diet-drug mystery grows as new research data emergeNew York, NY: Wall Street Journal; 1997. pp. B.1October 31.
689. Centers for Disease Control and Prevention (CDC) Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services interim public health recommendations, November 1997 MMWR Morbid Mortal Wkly Rep 1997;46:1061-1066.
690. FDA Home Page Center for Drug Evaluation & Research http://www.fda.gov/cder/ 1997Accessed November 2005.
691. Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension: International Primary Pulmonary Hypertension Study Group N Engl J Med 1996;335:609-616.
692. Mark EJ, Patalas ED, Chang HT, Evans RJ, Kessler SC. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine N Engl J Med 1997;337:602-606.
693. Dillon K, Putnam K, Avorn J. Death from irreversible pulmonary hypertension associated with short-t fenfluramine and phentermine JAMA 1997;278:1320-1326.
694. Thorson AH. Endocardial sclerosis and other heart lesions in the carcinoid disease Acta Med Scand Suppl 1958;278:99-119.
695. Redfield MM, Nicholson WJ, Edwards WD, Tajik AJ. Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations Ann Intern Med 1992; 117:50-52.
696. Pellikka PA, Tajik AJ, Khandheria BK, et al. Carcinoid heart disease: clinical and echocardiographic spectrum in 74 patients Circulation 1993;87:1188-1196.
697. Redfield MM. Ergot alkaloid heart diseaseIn: Hurst JW, editor. New Types of Cardiovascular Diseases: Topics in Clinical Cardiology. New York, NY: Igaku-Shoin Medical; 1994. pp. 63-76.
698. Robiolio PA, Rigolin VH, Wilson JS, et al. Carcinoid heart disease: correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography Circulation 1995;92:790-795.
699. Wilke A, Hesse H, Hufnagel G, Maisch B. Mitral, aortic and tricuspid valvular heart disease associated with ergotamine therapy for migraine Eur Heart J 1997;18:701-705.
700. Rothman RB, Baumann MH, Savage JE, et al. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications Circulation 2000;102:2836-2841.
701. Burger AJ, Sherman HB, Charlamb MJ, et al. Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months J Am Coll Cardiol 1999;34:1153-1158.
702. Tovar EA, Landa DW, Borsari BE. Dose effect of fenfluramine-phentermine in the production of valvular heart disease Ann Thorac Surg 1999;67:1213-1214.
703. Jollis JG, Landolfo CK, Kisslo J, Constantine GD, Davis KD, Ryan T. Fenfluramine and phentermine and cardiovascular findings: effect of treatment duration on prevalence of valve abnormalities Circulation 2000;101:2071-2077.
704. Lepor NE, Gross SB, Daley WL, et al. Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease Am J Cardiol 2000;86:107-110.
705. Burger AJ, Charlamb MJ, Singh S, Notarianni M, Blackburn GL, Sherman HB. Low risk of significant echocardiographic valvulopathy in patients treated with anorectic drugs Int J Cardiol 2001;79159-5.
706. Davidoff R, McTiernan A, Constantine G, et al. Echocardiographic examination of women previously treated with fenfluramine: long-term follow-up of a randomized, double-blind, placebo-controlled trial Arch Intern Med 2001;161:1429-1436.
707. Sachdev M, Miller WC, Ryan T, Jollis JG. Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies Am Heart J 2002;144:1065-1073.
708. Hensrud DD, Connolly HM, Grogan M, Miller FA, Bailey KR, Jensen, MD. Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine Mayo Clin Proc 1999;74:1191-1197.
709. Vagelos R, Jacobs M, Popp RL, Liang D. Reversal of Phen-Fen associated valvular regurgitation documented by serial echocardiography J Am Soc Echocardiogr 2002;15:653-657.
710. Bach DS, Rissanen AM, Mendel CM, et al. Absence of cardiac valve dysfunction in obese patients treated with sibutramine Obes Res 1999;7:363-369.
711. Glazer G. Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety Arch Intern Med 2001;161:1814-1824.
712. Pritchett AM, Morrison JF, Edwards WD, Schaff HV, Connolly HM, Espinosa RE. Valvular heart disease in patients taking pergolide Mayo Clin Proc 2002;77:1280-1286.
713. Flowers CM, Racoosin JA, Lu SL, Beitz JG. The US Food and Drug Administration's registry of patients with pergolide-associated valvular heart disease Mayo Clin Proc 2003;78:730-
731.
714. Van CG, Flamez A, Cosyns B, et al. Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease Lancet 2004;363: 1179-1183.
715. Handa N, McGregor CG, Danielson GK, et al. Valvular heart operation in patients with previous mediastinal radiation therapy Ann Thorac Surg 2001;71:1880-1884.
716. Handa N, McGregor CG, Danielson GK, et al. Coronary artery bypass grafting in patients with previous mediastinal radiation therapy J Thorac Cardiovasc Surg 1999;117:1136-1142.
717. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease JAMA 1993;270:1949-1955.
718. Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach J Am Coll Cardiol 1989;14:631 -638.
719. Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS. Infective endocarditis: an analysis based on strict case definitions Ann Intern Med 1981;94:505-518.
720. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings: Duke Endocarditis Service Am J Med 1994;96:200-209.
721. Habib G, Derumeaux G, Avierinos JF, et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis J Am Coll Cardiol 1999;33:2023-2029.
722. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis Clin Infect Dis 2000;30:633-638.
723. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America Circulation 2005;111:e3944-e3434.
724. Pesanti EL, Smith IM. Infective endocarditis with negative blood cultures: an analysis of 52 cases Am J Med 1979;66:43-50.
725. Van Scoy RE. Culture-negative endocarditis Mayo Clin Proc 1982;57:149-154. 726. Nunley DL, Perlman PE. Endocarditis: changing trends in epidemiology, clinical and microbiologic spectrum Postgrad Med 1993;93:235-238241-4, 247.
727. Daniel WG, Mugge A, Martin RP, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography N Engl J Med 1991;324:795-
800.
728. Shapiro SM, Young E, De Guzman S, et al. Transesophageal echocardiography in diagnosis of infective endocarditis Chest 1994;105:377-382.
729. Rubenson DS, Tucker CR, Stinson EB, et al. The use of echocardiography in diagnosing culture-negative endocarditis Circulation 1981;64:641-646.
730. DiNubile MJ. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users Ann Intern Med 1994;121:873-876.
731. Kaye D. Treatment of infective endocarditis Ann Intern Med 1996;124:606-608.
732. Francioli PB. Ceftriaxone and outpatient treatment of infective endocarditis Infect Dis Clin North Am 1993;7:97-115.
733. Clarkson PM, Barratt-Boyes BG. Bacterial endocarditis following homograft replacement of the aortic valve Circulation 1970;42:987-991.
734. Richardson JV, Karp RB, Kirklin JW, Dismukes WE. Treatment of infective endocarditis: a 10-year comparative analysis Circulation 1978;58:589-597.
735. Rossiter SJ, Stinson EB, Oyer PE, et al. Prosthetic valve endocarditis: comparison of heterograft tissue valves and mechanical valves J Thorac Cardiovasc Surg 1978;76:795-803.
736. Sweeney MS, Reul Jr GJ, Cooley DA, et al. Comparison of bioprosthetic and mechanical valve replacement for active endocarditis J Thorac Cardiovasc Surg 1985;90:676-680.
737. Calderwood SB, Swinski LA, Karchmer AW, Waternaux CM, Buckley MJ. Prosthetic valve endocarditis: analysis of factors affecting outcome of therapy J Thorac Cardiovasc Surg 1986;92:776-783.
738. Rocchiccioli C, Chastre J, Lecompte Y, Gandjbakhch I, Gibert C. Prosthetic valve endocarditis: the case for prompt surgical management J Thorac Cardiovasc Surg 1986;92:784-789.
739. Cowgill LD, Addonizio VP, Hopeman AR, Harken AH. A practical approach to prosthetic valve endocarditis Ann Thorac Surg 1987;43:450-457.
740. Arbulu A, Holmes RJ, Asfaw I. Tricuspid valvulectomy without replacement: twenty years' experience J Thorac Cardiovasc Surg 1991;102:917-922.
741. Glazier JJ, Verwilghen J, Donaldson RM, Ross DN. Treatment of complicated prosthetic aortic valve endocarditis with annular abscess formation by homograft aortic root replacement J Am Coll Cardiol 1991;17:1177-1182.
742. Haydock D, Barratt-Boyes B, Macedo T, Kirklin JW, Blackstone E. Aortic valve replacement for active infectious endocarditis in 108 patients: a comparison of freehand allograft valves with mechanical prostheses and bioprostheses J Thorac Cardiovasc Surg 1992;103:130-139.
743. Hendren WG, Morris AS, Rosenkranz ER, et al. Mitral valve repair for bacterial endocarditis J Thorac Cardiovasc Surg 1992;103:124-128.
744. McGiffin DC, Galbraith AJ, McLachlan GJ, et al. Aortic valve infection: risk factors for death and recurrent endocarditis after aortic valve replacement J Thorac Cardiovasc Surg 1992;104:511-520.
745. David TE, Armstrong S, Sun Z, Daniel L. Late results of mitral valve repair for mitral regurgitation due to degenerative disease Ann Thorac Surg 1993;56:7-12.
746. Sett SS, Hudon MP, Jamieson WR, Chow AW. Prosthetic valve endocarditis: experience with porcine bioprostheses J Thorac Cardiovasc Surg 1993;105:428-434.
747. Aranki SF, Santini F, Adams DH, et al. Aortic valve endocarditis: determinants of early survival and late morbidity Circulation 1994;90:II175-II182.
748. Petrou M, Wong K, Albertucci M, Brecker SJ, Yacoub MH. Evaluation of unstented aortic homografts for the treatment of prosthetic aortic valve endocarditis Circulation 1994;90:II198-II204.
749. Watanabe G, Haverich A, Speier R, Dresler C, Borst HG. Surgical treatment of active infective endocarditis with paravalvular involvement J Thorac Cardiovasc Surg 1994;107:171-177.
750. Yu VL, Fang GD, Keys TF, et al. Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only Ann Thorac Surg 1994;58:1073-1077.
751. Acar J, Michel PL, Varenne O, Michaud P, Rafik T. Surgical treatment of infective endocarditis Eur Heart J 1995;16(Suppl B):94-98.
752. Cormier B, Vahanian A. Echocardiography and indications for surgery Eur Heart J 1995;16(Suppl B):68-71.
753. David TE. The surgical treatment of patients with prosthetic valve endocarditis Semin Thorac Cardiovasc Surg 1995;7:47-53.
754. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications: multi-center retrospective study in Japan J Thorac Cardiovasc Surg 1995;110:1745-1755.
755. Rubinstein E, Lang R. Fungal endocarditis Eur Heart J 1995;16(Suppl B):84-89.
756. Acar C, Tolan M, Berrebi A, et al. Homograft replacement of the mitral valve: graft selection, technique of implantation, and results in forty-three patients J Thorac Cardiovasc Surg 1996;111:367-378.
757. Lytle BW, Priest BP, Taylor PC, et al. Surgical treatment of prosthetic valve endocarditis J Thorac Cardiovasc Surg 1996;111:198-207.
758. Delahaye JP, Poncet P, Malquarti V, Beaune J, Gare JP, Mann JM. Cerebrovascular accidents in infective endocarditis: role of anticoagulation Eur Heart J 1990;11:1074-1078.
759. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated leftsided native valve endocarditis in adults: risk classification for mortality JAMA 2003;289:1933-1940.
760. Sternik L, Zehr KJ, Orszulak TA, Mullany CJ, Daly RC, Schaff HV. The advantage of repair of mitral valve in acute endocarditis J Heart Valve Dis 2002; 11:91-97.
761. Iung B, Rousseau-Paziaud J, Cormier B, et al. Contemporary results of mitral valve repair for infective endocarditis J Am Coll Cardiol 2004;43:3 86-392.
762. Zegdi R, Debieche M, Latremouille C, et al. Long-term results of mitral valve repair in active endocarditis Circulation 2005;111:2532-2536.
763. Elkayam U. Pregnancy and cardiovascular diseaseIn: Zipes DP, Libby P, Bonow RO, Braunwald E, editors. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed.. Philadelphia, PA: Elsevier; 2005. pp. 1965.
764. de Boer K, ten Cate JW, Sturk A, Borm JJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy Am J Obstet Gynecol 1989;16095-00.
765. Immer FF, Bansi AG, Immer-Bansi AS, et al. Aortic dissection in pregnancy: analysis of risk factors and outcome Ann Thorac Surg 2003;76:309-314.
766. Bryant-Greenwood GD, Schwabe C. Human relaxins: chemistry and biology Endocr Rev 1994;15:5-26.
767. Marcus FI, Ewy GA, O'Rourke RA, Walsh B, Bleich AC. The effect of pregnancy on the murmurs of mitral and aortic regurgitation Circulation 1970;41:795-805.
768. Campos O, Andrade JL, Bocanegra J, et al. Physiologic multivalvular regurgitation during pregnancy: a longitudinal Doppler echocardiographic study Int J Cardiol 1993;40:265-272.
769. Reimold SC, Rutherford JD. Clinical practice: valvular heart disease in pregnancy N Engl J Med 2003;349:52-59.
770. Elkayam U, Bitar F. Valvular heart disease and pregnancy, part I: native valves J Am Coll Cardiol 2005;46:223-230.
771. Elkayam U, Bitar F. Valvular heart disease and pregnancy, part II: prosthetic valves J Am Coll Cardiol 2005;46:403-410.
772. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease Circulation 2001;104:515-521.
773. Siu SC, Colman JM, Sorensen S, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease Circulation 2002;105:2179-2184.
774. Rahimtoola SH, Durairaj A, Mehra A, Nuno I. Current evaluation and management of patients with mitral stenosis Circulation 2002;106:1183-1188.
775. Palacios IF, Block PC, Wilkins GT, Rediker DE, Daggett WM. Percutaneous mitral balloon valvotomy during pregnancy in a patient with severe mitral stenosis Cathet Cardiovasc Diagn 1988;15:109-111.
776. Safian RD, Berman AD, Sachs B, et al. Percutaneous balloon mitral valvuloplasty in a pregnant woman with mitral stenosis Cathet Cardiovasc Diagn 1988;15:103-108.
777. Esteves CA, Ramos AI, Braga SL, Harrison JK, Sousa JE. Effectiveness of percutaneous balloon mitral valvotomy during pregnancy Am J Cardiol 1991;68:930-934.
778. Ben Farhat M, Maatouk F, Betbout F, et al. Percutaneous balloon mitral valvuloplasty in eight pregnant women with severe mitral stenosis Eur Heart J 1992;13:1658-1664.
779. Chow WH, Chow TC, Wat MS, Cheung KL. Percutaneous balloon mitral valvotomy in pregnancy using the Inoue balloon catheter Cardiology 1992;81:182-185.
780. Kultursay H, Turkoglu C, Akin M, Payzin S, Soydas C, Akilli A. Mitral balloon valvuloplasty with transesophageal echocardiography without using fluoroscopy Cathet Cardiovasc Diagn 1992;27:317-321.
781. Ribeiro PA, Fawzy ME, Awad M, Dunn B, Duran CG. Balloon valvotomy for pregnant patients with severe pliable mitral stenosis using the Inoue technique with total abdominal and pelvic shielding Am Heart J 1992;124:1558-1562.
782. Ruzyllo W, Dabrowski M, Woroszylska M, Rydlewska-Sadowska W. Percutaneous mitral commissurotomy with the Inoue balloon for severe mitral stenosis during pregnancy J Heart Valve Dis 1992;1:209-212.
783. Patel JJ, Mitha AS, Hassen F, et al. Percutaneous balloon mitral valvotomy in pregnant patients with tight pliable mitral stenosis Am Heart J 1993;125:1106-1109.
784. Iung B, Cormier B, Elias J, et al. Usefulness of percutaneous balloon commissurotomy for mitral stenosis during pregnancy Am J Cardiol 1994;73:398-400.
785. Pavankumar P, Venugopal P, Kaul U, et al. Closed mitral valvotomy during pregnancy: a 20-year experience Scand J Thorac Cardiovasc Surg 1988;22:11-15.
786. Lao TT, Adelman AG, Sermer M, Colman JM. Balloon valvuloplasty for congenital aortic stenosis in pregnancy Br J Obstet Gynaecol 1993;100:1141-1142.
787. Banning AP, Pearson JF, Hall RJ. Role of balloon dilatation of the aortic valve in pregnant patients with severe aortic stenosis Br Heart J 1993;70:544-545.
788. Sheikh F, Rangwala S, DeSimone C, Smith HS, O'Leary AM. Management of the parturient with severe aortic incompetence J Cardiothorac Vasc Anesth 1995;9:575-577.
789. Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome Am J Obstet Gynecol 1995;173:1599-1606.
790. Elkayam U, Ostrzega E, Shotan A, Mehra A. Cardiovascular problems in pregnant women with the Marfan syndrome Ann Intern Med 1995;123:117-122.
791. Rossouw GJ, Knott-Craig CJ, Barnard PM, Macgregor LA, Van Zyl WP. Intracardiac operation in seven pregnant women Ann Thorac Surg 1993;55:1172-1174.
792. Goldstein I, Jakobi P, Gutterman E, Milo S. Umbilical artery flow velocity during maternal cardiopulmonary bypass Ann Thorac Surg 1995;60:1116-1118.
793. Sullivan HJ. Valvular heart surgery during pregnancy Surg Clin North Am 1995;75:59-
75.
794. Expert consensus document on management of cardiovascular diseases during pregnancy Eur Heart J 2003;24:761-781.
795. Rahimtoola SH. Choice of prosthetic heart valve for adult patients J Am Coll Cardiol 2003;41:893-904.
796. Wahlers T, Laas J, Alken A, Borst HG. Repair of acute type A aortic dissection after cesarean section in the thirty-ninth week of pregnancy J Thorac Cardiovasc Surg 1994;107:314-
315.
797. Jayaram A, Carp HM, Davis L, Jacobson SL. Pregnancy complicated by aortic dissection: caesarean delivery during extradural anaesthesia Br J Anaesth 1995;75:358-360.
798. Jamieson WR, Miller DC, Akins CW, et al. Pregnancy and bioprostheses: influence on structural valve deterioration Ann Thorac Surg 1995;60:S282-S286.
799. Dore A, Somerville J. Pregnancy in patients with pulmonary autograft valve replacement Eur Heart J 1997;18:1659-1662.
800. Iturbe-Alessio I, Fonseca MC, Mutchinik O, Santos MA, Zajarias A, Salazar E. Risks of anticoagulant therapy in pregnant women with artificial heart valves N Engl J Med 1986;315:1390-1393.
801. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses Br Heart J 1994;71:196-201.
802. Hung L, Rahimtoola SH. Prosthetic heart valves and pregnancy Circulation 2003;107:1240-1246.
803. Wong V, Cheng CH, Chan KC. Fetal and neonatal outcome of exposure to anticoagulants during pregnancy Am J Med Genet 1993;45:17-21.
804. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy J Am Coll Cardiol 2003;41:1633-1652.
805. Hirsh J, Fuster V, American Heart Association Guide to anticoagulant therapy, part 2: oral anticoagulants Circulation 1994;89:1469-1480.
806. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses J Am Coll Cardiol 1996;27:1698-1703.
807. Ginsberg JS, Hirsh J. Use of antithrombotic agents during pregnancy Chest 1995; 108:305S-311S.
808. Turpie AG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement N Engl J Med 1993;329:524-529.
809. Oakley CM. Pregnancy and prosthetic heart valves Lancet 1994;344:1643-1644.
810. Elkayam UR. Anticoagulation in pregnant women with prosthetic heart valves: a double jeopardy J Am Coll Cardiol 1996;27:1704-1706.
811. Ginsberg JS, Chan WS, Bates SM, Kaatz S. Anticoagulation of pregnant women with mechanical heart valves Arch Intern Med 2003;163:694-698.
812. Topol EJ. Anticoagulation with prosthetic cardiac valves Arch Intern Med 2003;163:2251-2252.
813. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature Arch Intern Med 2000;160:191-196.
814. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 2004;126:627S-644S.
815. Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease—native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 2004;126:457S-482S.
816. Warnes CA, Liberthson R, Danielson GK, et al. Task force 1: the changing profile of congenital heart disease in adult life J Am Coll Cardiol 2001;37:1170-1175.
817. Colan SD, Parness IA, Spevak PJ, Sanders SP. Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility J Am Coll Cardiol 1992;19:619-629.
818. Wagner HR, Ellison RC, Keane JF, Humphries OJ, Nadas AS. Clinical course in aortic stenosis Circulation 1977;56:I47-I56.
819. Keane JF, Driscoll DJ, Gersony WM, et al. Second natural history study of congenital heart defects: results of treatment of patients with aortic valvar stenosis Circulation 1993;87:I16-
I27.
820. McCrindle BW. Independent predictors of immediate results of percutaneous balloon aortic valvotomy in children: Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators Am J Cardiol 1996;77:286-293.
821. Moore P, Egito E, Mowrey H, Perry SB, Lock JE, Keane JF. Midterm results of balloon dilation of congenital aortic stenosis: predictors of success J Am Coll Cardiol 1996;27:1257-1263.
822. Ross DN. Replacement of aortic and mitral valves with a pulmonary autograft Lancet 1967;2:956-958.
823. Takkenberg JJ, Dossche KM, Hazekamp MG, et al. Report of the Dutch experience with the Ross procedure in 343 patients Eur J Cardiothorac Surg 2002;22:70-77.
824. Paparella D, David TE, Armstrong S, Ivanov J. Mid-term results of the Ross procedure J Card Surg 2001;16:338-343.
825. Elkins RC. The Ross operation: a 12-year experience Ann Thorac Surg 1999;68:S14-
S18.
826. Bacha EA, Hijazi ZM, Cao QL, et al. New therapeutic avenues with hybrid pediatric cardiac surgery Heart Surg Forum 2004;7:33-40.
827. Casselman FP, Gillinov AM, Akhrass R, Kasirajan V, Blackstone EH, Cosgrove DM. Intermediate-term durability of bicuspid aortic valve repair for prolapsing leaflet Eur J Cardiothorac Surg 1999;15:302-308.
828. Ruckman RN, Van Praagh R. Anatomic types of congenital mitral stenosis: report of 49 autopsy cases with consideration of diagnosis and surgical implications Am J Cardiol 1978;42:592-
601.
829. Moore P, Adatia I, Spevak PJ, et al. Severe congenital mitral stenosis in infants Circulation 1994;89:2099-2106.
830. Attie F, Rosas M, Rijlaarsdam M, et al. The adult patient with Ebstein anomaly: outcome in 72 unoperated patients Medicine (Baltimore) 2000;79:27-36.
831. Celermajer DS, Cullen S, Sullivan ID, Spiegelhalter DJ, Wyse RK, Deanfield JE. Outcome in neonates with Ebstein's anomaly J Am Coll Cardiol 1992;19:1041-1046.
832. Celermajer DS, Bull C, Till JA, et al. Ebstein's anomaly: presentation and outcome from fetus to adult J Am Coll Cardiol 1994;23:170-176.
833. Discigil B, Dearani JA, Puga FJ, et al. Late pulmonary valve replacement after repair of tetralogy of Fallot J Thorac Cardiovasc Surg 2001;121:344-351.
834. Kiziltan HT, Theodoro DA, Warnes CA, O'Leary PW, Anderson BJ, Danielson GK. Late results of bioprosthetic tricuspid valve replacement in Ebstein's anomaly Ann Thorac Surg 1998;66:1539-1545.
835. Koretzky ED, Moller JH, Korns ME, Schwartz CJ, Edwards JE. Congenital pulmonary stenosis resulting from dysplasia of valve Circulation 1969;40:43-53.
836. Nadas AS, Ellison RC, Weidman WH. Report from the Joint Study on the Natural History of Congenital Heart Defects Circulation 1977;56(Suppl I):I1 -I87.
837. O'Fallon WM, Weidman WH. Long-term follow-up of congenital aortic stenosis, pulmonary stenosis, and ventricular septal defect: report from the Second Joint Study on the Natural History of Congenital Heart Defects (NHS-2) Circulation 1993;87(Suppl I):I1 -I126.
838. Brock RC. The surgical treatment of pulmonic stenosis Br Heart J 1961 ;23337-3.
839. Jonas RA, Castaneda AR, Norwood WI, Freed, MD. Pulmonary valvotomy under normothermic caval inflow occlusion Aust N Z J Surg 1985;55:39-44.
840. Kan JS, White Jr RI, Mitchell SE, Gardner TJ. Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary-valve stenosis N Engl J Med 1982;307:540-542.
841. Stanger P, Cassidy SC, Girod DA, Kan JS, Lababidi Z, Shapiro SR. Balloon pulmonary valvuloplasty: results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry Am J Cardiol 1990;65:775-783.
842. Kaul UA, Singh B, Tyagi S, Bhargava M, Arora R, Khalilullah M. Long-term results after balloon pulmonary valvuloplasty in adults Am Heart J 1993;126:1152-1155.
843. Chen CR, Cheng TO, Huang T, et al. Percutaneous balloon valvuloplasty for pulmonic stenosis in adolescents and adults N Engl J Med 1996;335:21-25.
844. McCrindle BW. Independent predictors of long-term results after balloon pulmonary valvuloplasty: Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators Circulation 1994;89:1751-1759.
845. Driscoll D, Allen HD, Atkins DL, et al. Guidelines for evaluation and management of common congenital cardiac problems in infants, children, and adolescents: a statement for healthcare professionals from the Committee on Congenital Cardiac Defects of the Council on Cardiovascular Disease in the Young, American Heart Association Circulation 1994;90:2180-2188.
846. Murphy JG, Gersh BJ, Mair DD, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot N Engl J Med 1993;329:593-599.
847. Gatzoulis MA, Clark AL, Cullen S, Newman CG, Redington AN. Right ventricular diastolic function 15 to 35 years after repair of tetralogy of Fallot. Restrictive physiology predicts superior exercise performance. Circulation 1995;91:1775-1781.
848. Therrien J, Siu SC, Harris L, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot Circulation 2001;103:2489-2494.
849. Hazekamp MG, Kurvers MM, Schoof PH, et al. Pulmonary valve insertion late after repair of Fallot's tetralogy Eur J Cardiothorac Surg 2001;19:667-670.
850. Vliegen HW, van Straten A, de Roos A, et al. Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of Fallot Circulation 2002;106:1703-1707.
851. Therrien J, Siu SC, McLaughlin PR, Liu PP, Williams WG, Webb GD. Pulmonary valve replacement in adults late after repair of tetralogy of Fallot: are we operating too late? J Am Coll Cardiol 2000;36:1670-1675.
852. Grunkemeier GL, Li HH, Naftel DC, Starr A, Rahimtoola SH. Long-term performance of heart valve prostheses Curr Probl Cardiol 2000;2573-54.
853. Edmunds Jr LH, Clark RE, Cohn LH, Miller C, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations Ann Thorac Surg 1988;46:257-259.
854. Edmunds Jr LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations: the American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity Ann Thorac Surg 1996;62:932-935.
855. Edmunds Jr LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations: Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of the American Association for Thoracic Surgery and The Society of Thoracic Surgeons J Thorac Cardiovasc Surg 1996;112:708-711.
856. Rahimtoola SH. The problem of valve prosthesis-patient mismatch Circulation 1978;58:20-24.
857. Rahimtoola SH. Lessons learned about the determinants of the results of valve surgery Circulation 1988;78:1503-1507.
858. Grunkemeier GL, Starr A, Rahimtoola SH. Clinical performance of prosthetic heart valvesIn: Schlant RA, Alexander RW, editors. Hurst's The Heart. New York, NY: McGraw-Hill; 1998. pp. 1851-186678.
859. Sackett DL. Bias in analytic research J Chronic Dis 1979;32:51-63.
860. Rahimtoola SH. Some unexpected lessons from large multicenter randomized clinical trials Circulation 1985;72449-5.
861. Grunkemeier GL, Starr A. Alternatives to randomization in surgical studies J Heart Valve Dis 1992;1:142-151.
862. Bohm JO, Botha CA, Hemmer W, et al. Hemodynamic performance following the Ross operation: comparison of two different techniques J Heart Valve Dis 2004;13:174-180.
863. Cosgrove DM, Lytle BW, Gill CC, et al. In vivo hemodynamic comparison of porcine and pericardial valves J Thorac Cardiovasc Surg 1985;89:358-368.
864. Frater RW, Salomon NW, Rainer WG, Cosgrove III DM, Wickham E. The Carpentier-Edwards pericardial aortic valve: intermediate results Ann Thorac Surg 1992;53:764-771.
865. Pelletier LC, Leclerc Y, Bonan R, Crepeau J, Dyrda I. Aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: clinical and hemodynamic results J Card Surg 1988;3:405-412.
866. Walther T, Lehmann S, Falk V, et al. Prospectively randomized evaluation of stented xenograft hemodynamic function in the aortic position Circulation 2004;110:II74-II78.
867. Jamieson WR, Rosado LJ, Munro AI, et al. Carpentier-Edwards standard porcine bioprosthesis: primary tissue failure (structural valve deterioration) by age groups Ann Thorac Surg 1988;46:155-162.
868. Cohn LH, Collins Jr JJ, DiSesa VJ, et al. Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements Ann Surg 1989;210:435-442.
869. Jones EL, Weintraub WS, Craver JM, et al. Ten-year experience with the porcine bioprosthetic valve: interrelationship of valve survival and patient survival in 1,050 valve replacements Ann Thorac Surg 1990;49:370-383.
870. Jamieson WR, Tyers GF, Janusz MT, et al. Age as a determinant for selection of porcine bioprostheses for cardiac valve replacement: experience with Carpentier-Edwards standard bioprosthesis Can J Cardiol 1991;7:181-188.
871. Pansini S, Ottino G, Caimmi F, Del Ponte S, Morea M. Risk factors of primary tissue failure within the 11th postoperative year in 217 patients with porcine bioprostheses J Card Surg 1991;6:644-648.
872. Burdon TA, Miller DC, Oyer PE, et al. Durability of porcine valves at fifteen years in a representative North American patient population J Thorac Cardiovasc Surg 1992;103:238-251.
873. Burr LH, Jamieson WR, Munro AI, et al. Structural valve deterioration in elderly patient populations with the Carpentier-Edwards standard and supra-annular porcine bioprostheses: a comparative study J Heart Valve Dis 1992;1:87-91.
874. Pelletier LC, Carrier M, Leclerc Y, Dyrda I, Gosselin G. Influence of age on late results of valve replacement with porcine bioprostheses J Cardiovasc Surg (Torino) 1992;33:526-533.
875. Cosgrove DM, Lytle BW, Taylor PC, et al. The Carpentier-Edwards pericardial aortic valve: ten-year results J Thorac Cardiovasc Surg 1995;110:651-662.
876. Pelletier LC, Carrier M, Leclerc Y, Dyrda I. The Carpentier-Edwards pericardial bioprosthesis: clinical experience with 600 patients Ann Thorac Surg 1995;60:S297-S302. 877. Cohn LH, Collins Jr JJ, Rizzo RJ, Adams DH, Couper GS, Aranki SF. Twenty-year follow-up of the Hancock modified orifice porcine aortic valve Ann Thorac Surg 1998;66:S30-S34.
878. Le Tourneau T, Savoye C, McFadden EP, et al. Mid-term comparative follow-up after aortic valve replacement with Carpentier-Edwards and Pericarbon pericardial prostheses Circulation 1999; 100:II11-II16.
879. Jamieson WR, Lemieux, MD, Sullivan JA, Munro IA, Metras J, Cartier PC. Medtronic Intact porcine bioprosthesis experience to twelve years Ann Thorac Surg 2001;71:S278-S281.
880. Banbury MK, Cosgrove III DM, Thomas JD, et al. Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis Ann Thorac Surg 2002;73:1460-1465.
881. Westaby S, Jin XY, Katsumata T, Arifi A, Braidley P. Valve replacement with a stentless bioprosthesis: versatility of the porcine aortic root J Thorac Cardiovasc Surg 1998;116477-4.
882. Hvass U, Palatianos GM, Frassani R, Puricelli C, O'Brien M. Multicenter study of stentless valve replacement in the small aortic root J Thorac Cardiovasc Surg 1999; 117:267-272.
883. Yun KL, Sintek CF, Fletcher AD, et al. Aortic valve replacement with the freestyle stentless bioprosthesis: five-year experience Circulation 1999; 100:II17-II23.
884. Dellgren G, Feindel CM, Bos J, Ivanov J, David TE. Aortic valve replacement with the Toronto SPV: long-term clinical and hemodynamic results Eur J Cardiothorac Surg 2002;21:698-
702.
885. Collinson J, Henein M, Flather M, Pepper JR, Gibson DG. Valve replacement for aortic stenosis in patients with poor left ventricular function: comparison of early changes with stented and stentless valves Circulation 1999; 100:II1 -II5.
886. Walther T, Falk V, Langebartels G, et al. Prospectively randomized evaluation of stentless versus conventional biological aortic valves: impact on early regression of left ventricular hypertrophy Circulation 1999; 100 :II6-II10.
887. Williams RJ, Muir DF, Pathi V, MacArthur K, Berg GA. Randomized controlled trial of stented and stentless aortic bioprotheses: hemodynamic performance at 3 years Semin Thorac Cardiovasc Surg 1999;11:93-97.
888. Santini F, Bertolini P, Montalbano G, et al. Hancock versus stentless bioprosthesis for aortic valve replacement in patients older than 75 years Ann Thorac Surg 1998;66:S99-S103.
889. Cohen G, Christakis GT, Joyner CD, et al. Are stentless valves hemodynamically superior to stented valves?. A prospective randomized trial. Ann Thorac Surg 2002;73:767 -775.
890. Westaby S, Horton M, Jin XY, et al. Survival advantage of stentless aortic bioprostheses Ann Thorac Surg 2000;70:785-790.
891. Bach DS, Goldman B, Verrier E, et al. Eight-year hemodynamic follow-up after aortic valve replacement with the Toronto SPV stentless aortic valve Semin Thorac Cardiovasc Surg 2001;13:173-179.
892. Lund O, Chandrasekaran V, Grocott-Mason R, et al. Primary aortic valve replacement with allografts over twenty-five years: valve-related and procedure-related determinants of outcome J Thorac Cardiovasc Surg 1999;117:77-90.
893. Dossche KM, Defauw JJ, Ernst SM, Craenen TW, De Jongh BM, de la Riviere AB. Allograft aortic root replacement in prosthetic aortic valve endocarditis: a review of 32 patients Ann Thorac Surg 1997;63:1644-1649.
894. Dearani JA, Orszulak TA, Schaff HV, Daly RC, Anderson BJ, Danielson GK. Results of allograft aortic valve replacement for complex endocarditis J Thorac Cardiovasc Surg 1997;113:285-291.
895. Lytle BW, Sabik JF, Blackstone EH, Svensson LG, Pettersson GB, Cosgrove III DM. Reoperative cryopreserved root and ascending aorta replacement for acute aortic prosthetic valve endocarditis Ann Thorac Surg 2002;74:S1754-S1757.
896. Sabik JF. Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis Ann Thorac Surg 2002;74:650-659.
897. d'Udekem Y, David TE, Feindel CM, Armstrong S, Sun Z. Long-term results of operation for paravalvular abscess Ann Thorac Surg 1996;62:48-53.
898. d'Udekem Y, David TE, Feindel CM, Armstrong S, Sun Z. Long-term results of surgery for active infective endocarditis Eur J Cardiothorac Surg 1997;11:46-52.
899. Alexiou C, Langley SM, Stafford H, Lowes JA, Livesey SA, Monro JL. Surgery for active culture-positive endocarditis: determinants of early and late outcome Ann Thorac Surg 2000;69:1448-1454.
900. Leyh RG, Knobloch K, Hagl C, et al. Replacement of the aortic root for acute prosthetic valve endocarditis: prosthetic composite versus aortic allograft root replacement J Thorac Cardiovasc Surg 2004;127:1416-1420.
901. Melina G, Mitchell A, Amrani M, Khaghani A, Yacoub MH. Transvalvular velocities after full aortic root replacement: results from a prospective randomized trial between the homograft and the Medtronic Freestyle bioprosthesis J Heart Valve Dis 2002;11:54-58.
902. Ali A, Lim E, Halstead J, et al. Porcine or human stentless valves for aortic valve replacement?. Results of a 10-year comparative study. J Heart Valve Dis 2003;12:430-435.
903. Willems TP, Takkenberg JJ, Steyerberg EW, et al. Human tissue valves in aortic position: determinants of reoperation and valve regurgitation Circulation 2001;103:1515-1521.
904. Raja SG, Pozzi M. Ross operation in children and young adults: the Alder Hey case series BMC Cardiovasc Disord 2004;4:3-21.
905. Carr-White GS, Glennan S, Edwards S, et al. Pulmonary autograft versus aortic homograft for rereplacement of the aortic valve: results from a subset of a prospective randomized trial Circulation 1999;100(Suppl II):II103-II106.
906. Aklog L, Carr-White GS, Birks EJ, Yacoub MH. Pulmonary autograft versus aortic homograft for aortic valve replacement: interim results from a prospective randomized trial J Heart Valve Dis 2000;9:176-188.
907. Laforest I, Dumesnil JG, Briand M, Cartier PC, Pibarot P. Hemodynamic performance at rest and during exercise after aortic valve replacement: comparison of pulmonary autografts versus aortic homografts Circulation 2002;106(Suppl I):I57 -I62.
908. Davierwala PM, David TE, Armstrong S, Ivanov J. Aortic valve repair versus replacement in bicuspid aortic valve disease J Heart Valve Dis 2003;12:679-686.
909. Minakata K, Schaff HV, Zehr KJ, et al. Is repair of aortic valve regurgitation a safe alternative to valve replacement? J Thorac Cardiovasc Surg 2004;127:645-653.
910. Yacoub MH, Gehle P, Chandrasekaran V, Birks EJ, Child A, Radley-Smith R. Late results of a valve-preserving operation in patients with aneurysms of the ascending aorta and root J Thorac Cardiovasc Surg 1998;115:1080-1090. 911. Leyh RG, Schmidtke C, Sievers HH, Yacoub MH. Opening and closing characteristics of the aortic valve after different types of valve-preserving surgery Circulation 1999;100:2153-2160.
912. David TE, Armstrong S, Ivanov J, Feindel CM, Omran A, Webb G. Results of aortic valve-sparing operations J Thorac Cardiovasc Surg 2001;122:39-46.
913. David TE. Aortic valve sparing operations Ann Thorac Surg 2002;73:1029-1030.
914. David TE, Ivanov J, Armstrong S, Feindel CM, Webb GD. Aortic valve-sparing operations in patients with aneurysms of the aortic root or ascending aorta Ann Thorac Surg 2002;74:S1758-S1761.
915. Burkhart HM, Zehr KJ, Schaff HV, Daly RC, Dearani JA, Orszulak TA. Valve-preserving aortic root reconstruction: a comparison of techniques J Heart Valve Dis 2003;12:62-67.
916. Crestanello JA, Zehr KJ, Daly RC, Orszulak TA, Schaff HV. Is there a role for the left ventricle apical-aortic conduit for acquired aortic stenosis? J Heart Valve Dis 2004;13:57-62.
917. Taylor KM. The Edinburgh heart valve study Heart 2003;89:697-698.
918. Hwang MH, Burchfiel CM, Sethi GK, et al. Comparison of the causes of late death following aortic and mitral valve replacement. VA Co-operative Study on Valvular Heart Disease. J Heart Valve Dis 1994;3:17-24.
919. Lytle BW, Cosgrove DM, Taylor PC, et al. Primary isolated aortic valve replacement: early and late results J Thorac Cardiovasc Surg 1989;97:675-694.
919. Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients in the United States with prosthetic heart valves: should the ACC/AHA practice guidelines on valve selection be modified Circulation 2002;105:1336-1341.
920. Halstead JC, Tsui SS. Randomized trial of stentless versus stented bioprostheses for aortic valve replacement Ann Thorac Surg 2003;76:1338-1339.
921. Marchand MA, Aupart MR, Norton R, et al. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis Ann Thorac Surg 2001;71:S236-S239.
922. Doenst T, Borger MA, David TE. Long-term results of bioprosthetic mitral valve replacement: the pericardial perspective J Cardiovasc Surg 2004;45:449-454.
923. Stewart WJ, Currie PJ, Salcedo EE, et al. Intraoperative Doppler color flow mapping for decision-making in valve repair for mitral regurgitation: technique and results in 100 patients Circulation 1990;81:556-566.
924. Sheikh KH, Bengtson JR, Rankin JS, de Bruijn NP, Kisslo J. Intraoperative transesophageal Doppler color flow imaging used to guide patient selection and operative treatment of ischemic mitral regurgitation Circulation 1991;84:594-604.
925. Click RL, Abel, MD, Schaff HV. Intraoperative transesophageal echocardiography: 5 -year prospective review of impact on surgical management Mayo Clin Proc 2000;75:241 -247.
926. Nowrangi SK, Connolly HM, Freeman WK, Click RL. Impact of intraoperative transesophageal echocardiography among patients undergoing aortic valve replacement for aortic stenosis J Am Soc Echocardiogr 2001;14:863-866. 927. Kallmeyer IJ, Collard CD, Fox JA, Body SC, Shernan SK. The safety of intraoperative transesophageal echocardiography: a case series of 7200 cardiac surgical patients Anesth Analg 2001;92:1126-1130.
928. Quinones MA, Douglas PS, Foster E, et al. ACC/AHA clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence J Am Coll Cardiol 2003;41:687-708.
929. Eltzschig HK, Kallmeyer IJ, Mihaljevic T, Alapati S, Shernan SK. A practical approach to a comprehensive epicardial and epiaortic echocardiographic examination J Cardiothorac Vasc Anesth 2003;17:422-429.
930. Meloni L, Aru G, Abbruzzese PA, et al. Regurgitant flow of mitral valve prostheses: an intraoperative transesophageal echocardiographic study J Am Soc Echocardiogr 1994;7:36-46.
931. Bach DS, Deeb GM, Bolling SF. Accuracy of intraoperative transesophageal echocardiography for estimating the severity of functional mitral regurgitation Am J Cardiol 1995;76:508-512.
932. Grewal KS, Malkowski MJ, Piracha AR, et al. Effect of general anesthesia on the severity of mitral regurgitation by transesophageal echocardiography Am J Cardiol 2000;85:199-
203.
933. Omran AS, Woo A, David TE, Feindel CM, Rakowski H, Siu SC. Intraoperative transesophageal echocardiography accurately predicts mitral valve anatomy and suitability for repair J Am Soc Echocardiogr 2002;15:950-957.
934. McAnulty JH, Rahimtoola SH. Antithrombotic therapy in valvular heart diseaseIn: Schlant R, Alexander RW, editors. Hurst's The Heart. New York, NY: McGraw-Hill; 1998. pp. 1867-1874.
935. Cobanoglu A, Fessler CL, Guvendik L, Grunkemeier G, Starr A. Aortic valve replacement with the Starr-Edwards prosthesis: a comparison of the first and second decades of follow-up Ann Thorac Surg 1988;45:248-252.
936. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses Circulation 1994;89:635-641.
937. Heras M, Chesebro JH, Fuster V, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement J Am Coll Cardiol 1995;25:1111-1119.
938. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves N Engl J Med 1995;333:11-17.
939. Butchart EG, Lewis PA, Grunkemeier GL, Kulatilake N, Breckenridge IM. Low risk of thrombosis and serious embolic events despite low-intensity anticoagulation: experience with 1,004 Medtronic Hall valves Circulation 1988;78:I66-I77.
940. Saour JN, Sieck JO, Mamo LA, Gallus AS. Trial of different intensities of anticoagulation in patients with prosthetic heart valves N Engl J Med 1990;322:428-432.
941. Vogt S, Hoffmann A, Roth J, et al. Heart valve replacement with the Bjork-Shiley and St Jude Medical prostheses: a randomized comparison in 178 patients Eur Heart J 1990;11:583-591.
942. Butchart EG, Lewis PA, Bethel JA, Breckenridge IM. Adjusting anticoagulation to prosthesis thrombogenicity and patient risk factors: recommendations for the Medtronic Hall valve Circulation 1991;84: III61-III6 9.
943. Horstkotte D, Schulte H, Bircks W, Strauer B. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses J Heart Valve Dis 1993;2:291-301.
944. Horstkotte D, Schulte HD, Bircks W, Strauer BE. Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis J Thorac Cardiovasc Surg 1994;107:1136-1145.
945. Jegaden O, Eker A, Delahaye F, et al. Thromboembolic risk and late survival after mitral valve replacement with the St. Jude Medical valve Ann Thorac Surg 1994;58:1721-1728.
946. Acar J, Iung B, Boissel JP, et al. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves Circulation 1996;94:2107-2112.
947. Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves Chest 2001;119:220S-227S.
948. Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA. Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction J Am Coll Cardiol 1998;31:749-753.
949. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation N Engl J Med 1996;335:540-546.
950. Altman R, Rouvier J, Gurfinkel E, et al. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves J Thorac Cardiovasc Surg 1991;101:427 -431.
951. Albertal J, Sutton M, Pereyra D, et al. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement: a retrospective, non-randomized study J Heart Valve Dis 1993;2:302-307.
952. Hayashi J, Nakazawa S, Oguma F, Miyamura H, Eguchi S. Combined warfarin and antiplatelet therapy after St. Jude Medical valve replacement for mitral valve disease J Am Coll Cardiol 1994;23:672-677.
953. Cappelleri JC, Fiore LD, Brophy MT, Deykin D, Lau J. Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: a metaanalysis Am Heart J 1995;130:547-552.
954. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk: the Medical Research Council's General Practice Research Framework Lancet 1998;351:233-241.
955. Hirsh J, Dalen JE, Fuster V, Harker LB, Patrono C, Roth G. Aspirin and other platelet-active drugs: the relationship among dose, effectiveness, and side effects Chest 1995;108:247S-257S.
956. Turpie AGG. Antithrombotic therapy after heart valve replacementIn: Yusuf S, Carne J, Camm J, Fallon E, Gersh B, editors. Evidence Based Cardiology. London, UK: BMJ Publishing Books; 1998. pp. 905-911108.
957. Altman R, Boullon F, Rouvier J, Raca R, de la Fuente L, Favaloro R. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves J Thorac Cardiovasc Surg 1976;72:127-129.
958. Dale J, Myhre E, Storstein O, Stormorken H, Efskind L. Prevention of arterial thromboembolism with acetylsalicylic acid: a controlled clinical study in patients with aortic ball valves Am Heart J 1977;94:101-111.
959. Chesebro JH, Fuster V, Elveback LR, et al. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole Am J Cardiol 1983;51:1537-1541.
960. Turpie AG, Gunstensen J, Hirsh J, Nelson H, Gent M. Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement Lancet 1988;1:1242-1245.
961. Weibert RT, Le DT, Kayser SR, Rapaport SI. Correction of excessive anti coagulation with low-dose oral vitamin K1 Ann Intern Med 1997;126:959-962.
962. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 2004;126:204S-233S. 963. Yiu KH, Siu CW, Jim MH, et al. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves Am J Cardiol 2006;97:409-411.
964. Genewein U, Haeberli A, Straub PW, Beer JH. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence Br J Haematol 1996;92:479-485.
965. Eckman MH, Beshansky JR, Durand-Zaleski I, Levine HJ, Pauker SG. Anticoagulation for noncardiac procedures in patients with prosthetic heart valves: does low risk mean high cost? JAMA 1990;263:1513-1521.
966. Spyropoulos AC, Frost FJ, Hurley JS, Roberts M. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy Chest 2004;125:1642-1650.
967. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery N Engl J Med 1997;336:1506-1511.
968. Bryan AJ, Butchart EG. Prosthetic heart valves and anticoagulant management during non-cardiac surgery Br J Surg 1995;82:577-578.
969. Busuttil WJ, Fabri BM. The management of anticoagulation in patients with prosthetic heart valves undergoing non-cardiac operations Postgrad Med J 1995;71:390-392.
970. Tinker JH, Tarhan S. Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses: observations in 180 operations JAMA 1978;239:738-739.
971. Moreno-Cabral RJ, McNamara JJ, Mamiya RT, Brainard SC, Chung GK. Acute thrombotic obstruction with Bjork-Shiley valves: diagnostic and surgical considerations J Thorac Cardiovasc Surg 1978;75:321-330.
972. Copans H, Lakier JB, Kinsley RH, Colsen PR, Fritz VU, Barlow JB. Thrombosed Bjork-Shiley mitral prostheses Circulation 1980;61:169-174.
973. Kontos Jr GJ, Schaff HV. Thrombotic occlusion of a prosthetic heart valve: diagnosis and management Mayo Clin Proc 1985;60:118-122.
974. Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin Circulation 2004;110:1658-1663.
975. Morton MJ, McAnulty JH, Rahimtoola SH, Ahuja N. Risks and benefits of postoperative cardiac catheterization in patients with ball valve prostheses Am J Cardiol 1977;40:870-875.
976. Shapira Y, Herz I, Vaturi M, et al. Thrombolysis is an effective and safe therapy in stuck bileaflet mitral valves in the absence of high-risk thrombi J Am Coll Cardiol 2000;35:1874-1880.
977. Ozkan M, Kaymaz C, Kirma C, et al. Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography J Am Coll Cardiol 2000;35:1881-1889.
978. Tong AT, Roudaut R, Ozkan M, et al. Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry J Am Coll Cardiol 2004;43:77-84.
979. Dzavik V, Cohen G, Chan KL. Role of transesophageal echocardiography in the diagnosis and management of prosthetic valve thrombosis J Am Coll Cardiol 1991;18:1829-1833.
980. Gueret P, Vignon P, Fournier P, et al. Transesophageal echocardiography for the diagnosis and management of nonobstructive thrombosis of mechanical mitral valve prosthesis Circulation 1995;91:103-110.
981. Barbetseas J, Nagueh SF, Pitsavos C, Toutouzas PK, Quinones MA, Zoghbi WA. Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical, transthoracic and transesophageal echocardiographic parameters J Am Coll Cardiol 1998;32:1410-1417.
982. Birdi I, Angelini GD, Bryan AJ. Thrombolytic therapy for left sided prosthetic heart valve thrombosis J Heart Valve Dis 1995;4:154-159.
983. Horstkotte D, Burckhardt D. Prosthetic valve thrombosis J Heart Valve Dis 1995;4:141 -
153
984. Hurrell DG, Schaff HV, Tajik A. Thrombolytic therapy for obstruction of mechanical prosthetic valves Mayo Clin Proc 1996;71:605-613.
985. Lengyel M, Fuster V, Keltai M, et al. Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy: Consensus Conference on Prosthetic Valve Thrombosis J Am Coll Cardiol 1997;30:1521-1526.
986. Gupta D, Kothari SS, Bahl VK, et al. Thrombolytic therapy for prosthetic valve thrombosis: short- and long-term results Am Heart J 2000;140:906-916.
987. Roudaut R, Lafitte S, Roudaut MF, et al. Fibrinolysis of mechanical prosthetic valve thrombosis: a single-center study of 127 cases J Am Coll Cardiol 2003;41:653-658.
988. Alpert JS. The thrombosed prosthetic valve: current recommendations based on evidence from the literature J Am Coll Cardiol 2003;41:659-660.
989. Rahimtoola SH. Valve prosthesis-patient mismatch: an update J Heart Valve Dis 1998;7:207-210.
990. Pibarot P, Dumesnil JG. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention J Am Coll Cardiol 2000;36:1131-1141.
991. David TE. Is prosthesis-patient mismatch a clinically relevant entity? Circulation 2005;111:3186-3187.
992. Tasca G, Brunelli F, Cirillo M, et al. Impact of valve prosthesis-patient mismatch on left ventricular mass regression following aortic valve replacement Ann Thorac Surg 2005;79:505-510.
993. Rahimtoola SH. Early valve replacement for preservation of ventricular function? Am J Cardiol 1977;40:472-475.
994. Jamieson WR, Janusz MT, MacNab J, Henderson C. Hemodynamic comparison of second- and third-generation stented bioprostheses in aortic valve replacement Ann Thorac Surg 2001;71:S282-S284.
995. Milano AD, De Carlo M, Mecozzi G, et al. Clinical outcome in patients with 19 -mm and 21-mm St. Jude aortic prostheses: comparison at long-term follow-up Ann Thorac Surg 2002;73:37-43.
996. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study Am J Cardiol 1976;38:46-51.
997. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease N Engl J Med 1979;300:1350-1358.
998. Ramsdale DR, Bennett DH, Bray CL, Ward C, Beton DC, Faragher EB. Angina, coronary risk factors and coronary artery disease in patients with valvular disease: a prospective study Eur Heart J 1984;5:716-726.
999. Fuster V, Pearson TA, Abrams J, et al. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events: September 14-15, 1995 J Am Coll Cardiol 1996;27:957-1047.
1000. Grundy SM, Pasternak R, Greenland P, Smith Jr S, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology Circulation 1999;100:1481-1492.
1001. Bertrand ME, Lablanche JM, Tilmant PY, Thieuleux FP, Delforge MR, Carre AG. Coronary sinus blood flow at rest and during isometric exercise in patients with aortic valve disease. Mechanism of angina pectoris in presence of normal coronary arteries. Am J Cardiol 1981;47: 199-
205.
1002. Ross RS. Right ventricular hypertension as a cause of precordial pain Am Heart J 1961;61:134-135.
1003. Harris CN, Kaplan MA, Parker DP, Dunne EF, Cowell HS, Ellestad MH. Aortic stenosis, angina, and coronary artery disease. Interrelations. Br Heart J 1975;37:656-661.
1004. Graboys TB, Cohn PF. The prevalence of angina pectoris and abnormal coronary arteriograms in severe aortic valvular disease Am Heart J 1977;93:683-686.
1005. Hancock EW. Aortic stenosis, angina pectoris, and coronary artery disease Am Heart J 1977;93:382-393.
1006. Morrison GW, Thomas RD, Grimmer SF, Silverton PN, Smith DR. Incidence of coronary artery disease in patients with valvular heart disease Br Heart J 1980;44:630-637.
1007. Crochet D, Petitier H, de Laguerenne J, et al. Aortic stenosis in adults: contribution of catheterization to the study of associated lesions. Apropos of 137 cases. Arch Mal Coeur Vaiss 1983;76:1057-1064.
1008. Exadactylos N, Sugrue DD, Oakley CM. Prevalence of coronary artery disease in patients with isolated aortic valve stenosis Br Heart J 1984;51:121-124.
1009. Green SJ, Pizzarello RA, Padmanabhan VT, Ong LY, Hall MH, Tortolani AJ. Relation of angina pectoris to coronary artery disease in aortic valve stenosis Am J Cardiol 1985;55: 1063 -
1065.
1010. Chobadi R, Wurzel M, Teplitsky I, Menkes H, Tamari I. Coronary artery disease in patients 35 years of age or older with valvular aortic stenosis Am J Cardiol 1989;64:811 -812.
1011. Lombard JT, Selzer A. Valvular aortic stenosis: a clinical and hemodynamic profile of patients Ann Intern Med 1987;106:292-298.
1012. Dangas G, Khan S, Curry BH, Kini AS, Sharma SK. Angina pectoris in severe aortic stenosis Cardiology 1999;92:1-3.
1013. Adler Y, Vaturi M, Herz I, et al. Nonobstructive aortic valve calcification: a window to significant coronary artery disease Atherosclerosis 2002;161:193-197.
1014. Basta LL, Raines D, Najjar S, Kioschos JM. Clinical, haemodynamic, and coronary angiographic correlates of angina pectoris in patients with severe aortic valve disease Br Heart J 1975;37:150-157.
1015. Lacy J, Goodin R, McMartin D, Masden R, Flowers N. Coronary atherosclerosis in valvular heart disease Ann Thorac Surg 1977;23:429-435.
1016. Hakki AH, Kimbiris D, Iskandrian AS, Segal BL, Mintz GS, Bemis CE. Angina pectoris and coronary artery disease in patients with severe aortic valvular disease Am Heart J 1980;100:441-449.
1017. Saltups A. Coronary arteriography in isolated aortic and mitral valve disease Aust N Z J Med 1982;12:494-497.
1018. Marchant E, Pichard A, Casanegra P. Association of coronary artery disease and valvular heart disease in Chile Clin Cardiol 1983;6:352-356.
1019. Timmermans P, Willems JL, Piessens J, De Geest H. Angina pectoris and coronary artery disease in severe aortic regurgitation Am J Cardiol 1988;61:826-829.
1020. Alexopoulos D, Kolovou G, Kyriakidis M, et al. Angina and coronary artery disease in patients with aortic valve disease Angiology 1993;44:707-711.
1021. Mattina CJ, Green SJ, Tortolani AJ, et al. Frequency of angiographically significant coronary arterial narrowing in mitral stenosis Am J Cardiol 1986;57:802-805.
1022. Chun PK, Gertz E, Davia JE, Cheitlin, MD. Coronary atherosclerosis in mitral stenosis Chest 1982;81:36-41.
1023. Gahl K, Sutton R, Pearson M, Caspari P, Lairet A, McDonald L. Mitral regurgitation in coronary heart disease Br Heart J 1977;39:13-18.
1024. Enriquez-Sarano M, Klodas E, Garratt KN, Bailey KR, Tajik AJ, Holmes Jr DR. Secular trends in coronary atherosclerosis—analysis in patients with valvular regurgitation N Engl J Med 1996;335:316-322.
1025. Breisblatt WM, Cerqueira M, Francis CK, Plankey M, Zaret BL, Berger HJ. Left ventricular function in ischemic mitral regurgitation—a precatheterization assessment Am Heart J 1988;115:77-82.
1026. Zeldis SM, Hamby RI, Aintablian A. The clinical and hemodynamic significance of mitral regurgitation in coronary artery disease Cathet Cardiovasc Diagn 1980;6:225-232.
1027. Lin SS, Lauer MS, Asher CR, et al. Prediction of coronary artery disease in patients undergoing operations for mitral valve degeneration J Thorac Cardiovasc Surg 2001;121:894-901.
1028. Osbakken MD, Bove AA, Spann JF. Left ventricular regional wall motion and velocity of shortening in chronic mitral and aortic regurgitation Am J Cardiol 1981;47:1005-1009.
1029. Kupari M, Virtanen KS, Turto H, et al. Exclusion of coronary artery disease by exercise thallium-201 tomography in patients with aortic valve stenosis Am J Cardiol 1992;70:635-640.
1030. Baroni M, Maffei S, Terrazzi M, Palmieri C, Paoli F, Biagini A. Mechanisms of regional ischaemic changes during dipyridamole echocardiography in patients with severe aortic valve stenosis and normal coronary arteries Heart 1996;75:492-497.
1031. Bailey IK, Come PC, Kelly DT, et al. Thallium-201 myocardial perfusion imaging in aortic valve stenosis Am J Cardiol 1977;40:889-899.
1032. Huikuri HV, Korhonen UR, Ikaheimo MJ, Heikkila J, Takkunen JT. Detection of coronary artery disease by thallium imaging using a combined intravenous dipyridamole and isometric handgrip test in patients with aortic valve stenosis Am J Cardiol 1987;59:336-340.
1033. Rask LP, Karp KH, Eriksson NP, Mooe T. Dipyridamole thallium-201 single-photon emission tomography in aortic stenosis: gender differences Eur J Nucl Med 1995;22:1155-1162.
1034. Samuels B, Kiat H, Friedman JD, Berman DS. Adenosine pharmacologic stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis: diagnostic efficacy and comparison of clinical, hemodynamic and electrocardiographic variables with 100 age-matched control subjects J Am Coll Cardiol 1995;25:99-106.
1035. Van TA. The value of myocardial perfusion imaging for diagnosing coronary artery disease in patients with aortic valve stenosis Adv Cardiol 2002;39:61-69.
1036. Mattila S, Harjula A, Jarvinen A, Kyllonen KE, Tala P. Combined valve replacement and myocardial revascularization: factors influencing early and late results Scand J Thorac Cardiovasc Surg 1984;18:49-52.
1037. Donzeau-Gouge P, Blondeau P, Enriquez O, et al. Calcified aortic stenosis and coronary disease: apropos of 115 surgically-treated cases [in French] Arch Mal Coeur Vaiss 1984;77:856-864.
1038. Craver JM, Weintraub WS, Jones EL, Guyton RA, Hatcher Jr CR. Predictors of mortality, complications, and length of stay in aortic valve replacement for aortic stenosis Circulation 1988;78:I85-I90.
1039. Stahle E, Bergstrom R, Nystrom SO, Hansson HE. Early results of aortic valve replacement with or without concomitant coronary artery bypass grafting Scand J Thorac Cardiovasc Surg 1991;25:29-35.
1040. Aranki SF, Rizzo RJ, Couper GS, et al. Aortic valve replacement in the elderly: effect of gender and coronary artery disease on operative mortality Circulation 1993;88:II17 -II23.
1041. Loop FD, Phillips DF, Roy M, Taylor PC, Groves LK, Effler DB. Aortic valve replacement combined with myocardial revascularization: late clinical results and survival of surgically-treated aortic valve patients with and without coronary artery disease Circulation 1977;55:169-173.
1042. Macmanus Q, Grunkemeier G, Lambert L, Dietl C, Starr A. Aortic valve replacement and aorta-coronary bypass surgery: results with perfusion of proximal and distal coronary arteries J Thorac Cardiovasc Surg 1978;75:865-869.
1043. Nunley DL, Grunkemeier GL, Starr A. Aortic valve replacement with coronary bypass grafting: significant determinants of ten-year survival J Thorac Cardiovasc Surg 1983;85:705-711.
1044. Kay PH, Nunley D, Grunkemeier GL, Garcia C, McKinley CL, Starr A. Ten-year survival following aortic valve replacement: a multivariate analysis of coronary bypass as a risk factor J Cardiovasc Surg (Torino) 1986;27:494-499.
1045. Mullany CJ, Elveback LR, Frye RL, et al. Coronary artery disease and its management: influence on survival in patients undergoing aortic valve replacement J Am Coll Cardiol 1987;10:66-72.
1046. Czar LSC, Gray RJ, Stewart ME, De Robertis M, Chaux A, Matloff JM. Reduction in sudden late death by concomitant revascularization with aortic valve replacement J Thorac Cardiovasc Surg 1988;95:390-400.
1047. Lytle BW, Cosgrove DM, Goormastic M, Loop FD. Aortic valve replacement and coronary bypass grafting for patients with aortic stenosis and coronary artery disease: early and late results Eur Heart J 1988;9(Suppl E):143-147.
1048. Lund O, Nielsen TT, Pilegaard HK, Magnussen K, Knudsen MA. The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis J Thorac Cardiovasc Surg 1990;100:327-337.
1049. Iung B, Drissi MF, Michel PL, et al. Prognosis of valve replacement for aortic stenosis with or without coexisting coronary heart disease: a comparative study J Heart Valve Dis 1993;2:430-439.
1050. Lytle BW, Cosgrove DM, Loop FD, et al. Replacement of aortic valve combined with myocardial revascularization: determinants of early and late risk for 500 patients, 1967-1981 Circulation 1983;68:1149-1162.
1051. Magovern JA, Pennock JL, Campbell DB, et al. Aortic valve replacement and combined aortic valve replacement and coronary artery bypass grafting: predicting high risk groups J Am Coll Cardiol 1987;9:38-43.
1052. Schaff HV, Bixler TJ, Flaherty JT, et al. Identification of persistent myocardial ischemia in patients developing left ventricular dysfunction following aortic valve replacement Surgery 1979;86:70-77.
1053. Hwang MH, Hammermeister KE, Oprian C, et al. Preoperative identification of patients likely to have left ventricular dysfunction after aortic valve replacement. Participants in the Veterans Administration Cooperative Study on Valvular Heart Disease. Circulation 1989;80:I65-176.
1054. Roberts DL, DeWeese JA, Mahoney EB, Yu PN. Long-term survival following aortic valve replacement Am Heart J 1976;91:311-317.
1055. Galvin I, Mosieri J, Paneth M, Gibson D. An analysis of isolated aortic valve surgery and combined procedures in patients over 70 years of age J Cardiovasc Surg (Torino) 1988;29:577-581.
1056. Cha SD, Naeem SM, Maranhao V, Gooch AS. Sequential study of left ventricular function in aortic valvular stenosis Cathet Cardiovasc Diagn 1982;8:145-154.
1057. Collins Jr JJ, Aranki SF. Management of mild aortic stenosis during coronary artery bypass graft surgery J Card Surg 1994;9:145-147.
1058. Fiore AC, Swartz MT, Naunheim KS, et al. Management of asymptomatic mild aortic stenosis during coronary artery operations Ann Thorac Surg 1996;61:1693-1697.
1059. Hoff SJ, Merrill WH, Stewart JR, Bender Jr HW. Safety of remote aortic valve replacement after prior coronary artery bypass grafting Ann Thorac Surg 1996;61:1689-1691.
1060. Leprince P, Tsezana R, Dorent R, et al. Reoperation for aortic valve replacement after myocardial revascularization Arch Mal Coeur Vaiss 1996;89:335-339.
1061. Odell JA, Mullany CJ, Schaff HV, Orszulak TA, Daly RC, Morris JJ. Aortic valve replacement after previous coronary artery bypass grafting Ann Thorac Surg 1996;62:1424-1430.
1062. Phillips BJ, Karavas AN, Aranki SF, et al. Management of mild aortic stenosis during coronary artery bypass surgery: an update, 1992-2001 J Card Surg 2003;18:507-511.
1063. Eitz T, Kleikamp G, Minami K, Gleichmann U, Korfer R. Aortic valve surgery following previous coronary artery bypass grafting: impact of calcification and leaflet movement Int J Cardiol 1998;64:125-130.
1064. Hochrein J, Lucke JC, Harrison JK, et al. Mortality and need for reoperation in patients with mild-to-moderate asymptomatic aortic valve disease undergoing coronary artery bypass graft alone Am Heart J 1999;138:791-797.
1065. Hilton TC. Aortic valve replacement for patients with mild to moderate aortic stenosis undergoing coronary artery bypass surgery Clin Cardiol 2000;23:141-147.
1066. Eitz T, Kleikamp G, Minami K, Korfer R. The prognostic value of calcification and impaired valve motion in combined aortic stenosis and coronary artery disease J Heart Valve Dis 2002;11:713-718.
1067. ACC/AHA Task Force on Practice Guidelines Manual for ACC/AHA Guideline Writing Committees: Methodologies and Policies from the ACC/AHA Task Force on Practice Guidelines http://www.acc.org/qualityandscience/clinical/manual/pdfs/methodology.pdf и http: / / circ.ahaj ournal s.org/manual/ 2002Accessed June 2007.
1068. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J Am Coll Cardiol 2006;48:e1-e148.
1069. Nishimura RA, Carabello BA, Faxon DP, et al. ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis prophylaxis J Am Coll Cardiol 2008;52:676-686.
1070. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation 2007;116:1736-1754.
1071. Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular devicerelated infections Circulation 2003;108:2015-2031.
1072. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Adults With Congenital Heart Disease) J Am Coll Cardiol 2008In press.
1073. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology Eur Heart J 2004;25:267-276.
1074. Gould FK, Elliott TS, Foweraker J, et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy J Antimicrob Chemother 2006;57:1035-1042.



 
« Ведение пациентов с нестабильной стенокардией / инфарктом миокарда без подъема сегмента ST   Вирусный гепатит у детей »